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Abstract 
Elderly Patient Adherence to Ocular Pharmaceuticals. Impact of Educational and 
Physical Barriers 
Lucky M. Wagner, M.S. Minnesota State University, Mantakto, May 2015 
 
The purpose of this research was to assess and evaluate elderly patient’s attitudes 
and behavior regarding educational and physical barriers and the impact on adherence to 
ocular pharmaceuticals. A 19 question survey was developed and in order to collect data. 
The survey was administered in person at the Edina Senior Center and the Burnsville 
Senior Center and online via Zoomerang survey software regarding elderly patient 
attitudes on educational and physical barriers and their impact on ocular pharmaceutical 
adherence. Findings from this study indicate elderly patients treating an ocular condition 
with ocular pharmaceuticals expressed strong agreement with improving upon both 
educational and physical barriers as beneficial. Participants described their desire to 
address both barriers with eye care providers and with the ocular pharmaceutical 
products. Recommendations for further study included investigation of possible 
interventions addressing the impact of educational and physical barriers to elderly patient 
adherence to ocular pharmaceuticals. To conclude, health education professionals can 
provide education strategies to elderly patients by integrating information regarding 
educational and physical barriers to ocular pharmaceutical adherence by partnering with 
eye care providers, other healthcare professionals dispensing ocular pharmaceuticals, and 
the manufacturers of ocular pharmaceuticals. 
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Chapter I: Introduction 
Visual impairment is a common consequence of aging, according to the National 
Eye Institute (n.d., para. 1) “as you age, you are at higher risk of developing age-related 
eye diseases and conditions.” Age is considered a risk indicator for developing eye 
diseases and conditions for the aging population. Furthermore, with increasing age 
related vision diseases and conditions there is an increased use of pharmaceuticals as part 
of ocular therapy. Wilson et al. (2007, p.7) report, “forty percent of older adults take five 
or more prescription medications a day.” While the management of multiple medication 
therapies is important, patient’s adherence to their prescribed ocular therapy is also 
critical to the successful treatment of vision impairment or a vision related condition. 
Medication adherence rates for ocular pharmaceuticals are considered low. According to 
Wick (2012, para.1) these adherence rates drop “to between 50% and 80% within 6 
months to a year.” Because of this low medication adherence rate, it is important to 
consider how significant proper instillation of ocular pharmaceutics, such as eye drops, is 
to treatment. Medication adherence affects the success and effectiveness of a patient’s 
therapy.  
The problem of failing to correctly self-administer ocular pharmaceuticals is a 
substantial health care concern because non-adherence to ocular pharmaceutical therapy 
is likely to result in negative consequences to the healthcare system and an individual’s 
health. Chisholm-Burns and Spivey (2011, p. 826) discuss how the “consequences of non 
adherence include worsening condition, increased comorbid diseases, increased health 
care costs, and death.” These consequences of non-adherence can reduce the success of 
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the prescribed ocular therapy in an individual. Poor medication adherence to ocular 
pharmaceutical also burdens the healthcare system. Costs are compounded from wasted 
medication, extra resources are needed to treat health complications related to failed 
therapy, and the need to extend prolonged treatment of preventable failed therapy. 
Statement of the Problem  
 
Health educators must understand the educational and physical barriers 
preventing the optimum utilization of eye drops. They must also understand how these 
barriers affect adherence to prescribed ocular pharmaceutical therapy. A better 
understanding of the impact of these barriers can improve patient care and success of 
ocular therapy in elderly patients.  Kass, Gordon, Morley, Meltzer, and Goldberg (1987) 
explains that improving the understanding of the individual needs of the patients and their 
difficulties with eye drops will lead to better adaptive patient care. Any deviation from 
proper instillation of ocular pharmaceuticals can result in a decreased successful 
treatment rate. Less than proper instillation of a medicated eye drop can negatively 
impact the success of a prescribed ocular pharmaceutical therapy. The patient’s recovery 
from a condition or illness is potentially slowed down, risk for relapse of the condition or 
illness increases, or causes undue harm to the patient. As described by Marek and Antle 
(2008, p.1), “many of the risk factors related to inadequate medication management are 
items that are more prevalent in older adults living in the community.” Therefore, this 
research study focuses on elderly persons aged 65 years and older who are particularly 
susceptible and at high risk to these educational and physical barriers.  
Educational barriers are potentially instructional pitfalls for elderly persons for 
not understanding how to instill their prescribed eye drops correctly. Freda (2004) 
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discussed how increasingly, however, appropriately intended comprehensive patient 
education has become more difficult to accomplish. Instructional pitfalls include 
directions that are difficult to follow, confusing terminology or word choice in the 
directions, and a lack of visual or demonstrational guidance of how to correctly instill eye 
drops. These instructional pitfalls are educational barriers that may impede an elderly 
patient’s understanding of how to correctly use eye drops and instill the medication as 
prescribed.  
For this population of elderly patients, physical barriers to proper use of eye drops 
include mechanical disadvantages. Burns and Mulley (1992) explain that the majority of 
patients experienced some difficulty with the instillation of their drops. Some of these 
mechanical disadvantages are the inability to see and read instructions and limitations in 
capability to expel an eye drop from the container. It is important for health education 
professionals to understand why these educational and physical barriers are significant 
concerns to this study population. This knowledge permits health education professionals 
to assist in the improvement of patient adherence rates and optimize the beneficial health 
outcome elderly patients obtain from satisfactory adherence to ocular pharmaceuticals. 
Significance of the Problem  
From an ecological perspective, the problem of low patient adherence rate of 
pharmaceuticals is rather large and expansive. At the community and social group levels, 
the National Community Pharmacists Association (2013) estimates an added cost of $290 
billion annually resulting from non-adherence to prescribed medication therapy. This is a 
significant amount of money that could be returned to the healthcare system to mitigate 
monies lost to fraud, waste, and abuse of medications. Repurposed monies associated 
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with non-adherence to prescription medication could be used to improve healthcare 
outcomes. At the individual level, non-adherence has significant and grave consequences. 
According to Ho, Bryson, and Rumsfeld (2009, p.3029) “non-adherence causes 
approximately 30 to 50% of treatment failures and 125,000 deaths annually.” 
Understanding educational and physical barriers that impact medication non-adherence 
can prevent these failures that cause harm, injury, and even death. It is evident from these 
studies that this problem has substantial impact at the community and individual levels. 
A review of the available literature reveals that ocular pharmaceuticals are an 
under-assessed classification of medications for patient adherence rates. Therefore this 
research study, which focuses on educational and physical barriers for proper instillation 
of this class of medications, will add its observations and findings to the current health 
education literature. Additionally, the outcomes of this research study have potential for 
interdisciplinary use. Evaluating these two types of barriers can have translational 
benefits. The survey instrument developed for this research study can be used for 
subsequent study opportunities. The findings can be applied to other classes of 
medications or pharmaceutical therapies. There are patient and provider education 
materials, communication models, and potential intervention strategies that could be 
implemented and incorporated into multiple therapy management plans to lessen the 
impact of educational and physical barriers. 
At multiple levels, from the community and social group to the individual, a 
better understanding of how educational and physical barriers impact patient adherence 
rates has the potential to improve health outcomes. These improvements could reduce 
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financial burden to health care system and progress patient’s health by maximizing the 
health benefits from properly adhering to their prescribed ocular therapy.  
Research Questions  
1. For	  elderly	  patients,	  how can the educational barrier of a lack of understanding 
how to properly instill ocular pharmaceuticals be addressed and mitigated?  
2. For	  elderly	  patients,	  how can physical barriers be addressed to improve the 
ability to properly self-administer eye drops as prescribed?  
Limitations  
Limitations of this research study include the following resource, participant, and 
methodology limitations: 
1. Limited time frame for research development.  
2. Limited time frame for data collection. 
3. Limited financial resources may limit the sample size. 
4. Obtaining sufficient sample size for the findings to have practical statistical 
significance. 
5.  Reliance on participant self-report and self-admission to their own educational 
or physical limitations.  
6.   Confidentiality agreements may also limit the sample size of the study. 
7.  Data collection will be gathered primarily through printed survey. 
 Delimitations   
1. Sample population- Age restriction (elderly patients aged 65 years and older), 
number of willing elderly patient participants, and identifying patients who are 
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currently diagnosed with a condition requiring a prescribed ocular pharmaceutical 
therapy. 
2. Time frame- Time is defined by the researcher’s status as a graduate student 
conducting a study in two 15-week academic semesters. 
 Assumptions  
The main assumption of this research study is that significant portions of ocular 
pharmaceutical (eye drop) users are elderly persons aged 65 years and older. This 
assumption is appropriate for this research study because there is a relationship between 
age and the number of prescribed medications for an individual. According to Hwang, 
Weller, Ireys, and Anderson (2001, p.267) for seniors “Out-of-pocket spending for 
prescription drugs was substantial.” An extension of this assumption is that a higher 
proportion of older adults would also represent the larger portion of patients prescribed 
eye drops for ocular pharmaceutical therapy.  
 Definition of Terms   
The following terms and definitions are included in this research to serve in the 
operational understanding of ocular pharmaceutical therapy. A pharmacy perspective of 
healthcare is applied towards the research questions in this study. 
• Instillation: As defined by Hopper (2014, p. 144) as, “to place into; instructions 
are commonly used for ophthalmic or otic drugs, as examples.” 
• Medication Adherence: The Agency for Healthcare Research and Quality defines, 
(as cited in Centers for Disease Control and Prevention (CDC) 2013, presentation 
slide 5) “the patients conformance with the provider’s recommendation with 
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respect to timing, dosage, and frequency of medication –taking during the 
prescribed length of time.” 
• Non-Adherence: Is defined by the American College of Preventative Medicine 
(2011, para.3) as, “the extent to which a patient’s behavior (in terms of taking 
medication, following a diet, modifying habits, or attending clinics) coincides 
with medical or health advice.” 
• Ophthalmic Solutions: Are defined by the Aldrich and colleagues (2013, p.4) as, 
“sterile solutions intended for instillation in the eye.” 
• Persistence: The Agency for Healthcare Research and Quality defines (as stated 
by the CDC, 2013, presentation slide 5) as the, “duration of time patient takes 
medication, from initiation to discontinuation of therapy.” 
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Chapter II: Literature Review 
Introduction 
An appraisal of current professional literature found that there is a moderate 
amount of research available about elderly patient adherence to prescribed medications. 
There are fewer studies on patients who are using eye drops as part of ocular 
pharmaceutical therapy. Studies that concentrate specifically on educational and physical 
barriers impacting elderly patient adherence to prescribed ocular medications are even 
more scant. This review of the literature related to this study’s research questions focus 
on analyzing the information available on educational and physical barriers. This review 
of the related literature is primarily an integrative literature review and approaches the 
evaluation of educational and physical barriers with a pharmacy perspective to appraise 
significant historical studies and recent research. A literature review matrix of the 
literature reviewed for this thesis is available. (See appendix A). 
This chapter concentrates on describing the educational and physical barriers and 
reviewing studies designed to address and evaluate their impact on elderly patients 
undergoing ocular pharmaceutical therapy. A discussion of recommendations from the 
studies is also included. This integrated literature review of studies related to these two 
barriers is critical because they strongly affect elderly patient adherence rates for ocular 
pharmaceutical therapy. According to the National Eye Institute (n.d., para. 1) “as you 
age, you are at higher risk of developing age-related eye diseases and conditions.”  This 
review centers on this elderly population because they are more likely than younger aged 
persons to be treated with ocular pharmaceuticals for an ocular condition or disease.  
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A critical review and evaluation of the available literature is a form of best 
practice, explained by Cottrell and McKenzie (2011, p.73) as  “the concept of using 
evidence that result from the critical review of multiple research and evaluation studies 
that substantiate efficacy of an intervention in a certain population.” Evaluating the 
history of research and works on these barriers connects previous works to the research 
questions posed in this study. This review identifies how health education research 
addressed educational and physical barriers that impact self-instillation of ocular 
pharmaceuticals and affect elderly patient adherence rates. 
Timeframe of literature reviewed 
The timeframe of the literature reviewed is defined by the advent of ocular 
pharmaceuticals to current date. Komatsu (2006) outlined the introduction of Federal 
Drug Administration (FDA) approved ocular pharmaceutical drug classes as follows; 
Pilocarpine preparations have been used since the 1870s. In the 1980s, beta-blockers 
were developed. Then in 1999, prostaglandin-type ophthalmic preparations were 
introduced to the drug market. This literature describes studies that focus on how 
educational and physical barriers impact a specific administrative class of ocular 
pharmaceuticals, that is, eye drops.  
Structure and Organization 
This literature review uses a parallel structure to describe both educational and 
physical barriers and directs the audience through historical works to recent studies. 
Pivotal studies are highlighted as they related to each barrier, elderly patient adherence 
rates, and the success rates of self-instillation. A historical background demonstrates 
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existing knowledge is available to address the research questions. It is important to show 
the trajectory of where research began to where the health education field is today. This 
also review emphasizes successes and failures in practice. 
Health Education Theories and Models 
This review of the existing literature and research studies found two prominent 
theories related to educational and physical barriers impacting elderly patient adherence 
of prescribed ocular pharmaceuticals- the Health Belief Model and Social Cognitive 
Theory. Both older and newer health education research gave credit to this model and 
theory. Rosenstock, Strecher, and Becker (1988) recognized that the Health Belief 
Model, Social Cognitive Theory, self-efficacy, and locus of control have all been applied 
with varying success to problems of explaining, predicting, and influencing behavior. 
From this review of professional literatures the Health Belief Model and Social Cognitive 
Theory has provided decades of strong support. I found this conclusion true, particularly 
for patient adherence to medications. 
Health Belief Model.  The Health Belief Model is a tried and true model. It is 
applicable to research about the educational and physical barriers impacting elderly 
patient ocular pharmaceutical adherence rates. A concept from the Health Belief Model, 
perceived barriers, lends itself to addressing research questions focused on barriers to 
health outcomes. According to Janz and Becker (1984, p.556) perceived barriers “proved 
to be the most powerful of the Health Belief Model dimensions across the various study 
designs and behaviors.” This early work on perceived barriers is a significant component 
of the Health Belief Model. The concept illuminated how important educational and 
physical barriers are when factored into success of elderly patient adherence to eye drops. 
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The Health Belief Model is a suitable choice to provide foundational support for this 
research study. 
Review of the literature also focused on the prominence of the Health Belief 
Model. It continues to be recognized as an applicable model for researching the 
contributing factors of elderly patient adherence to medications. Glanz, Rimer, and 
Viswanath (2008, p.42) stated, “it is among the most widely applied theoretical 
foundations for the study of health behavior change. The HBM is appealing and useful to 
a wide range of professionals concerned with behavior change.” Seminal research studies 
have used the Health Belief Model to design and evaluate interventions intended to alter 
health behavior. This literature review found the model was applied to barriers impacting 
elderly patient adherence of medication for a variety of health conditions, including but 
not limited to chronic health conditions to specific illnesses such as diabetes and 
glaucoma. Healthcare providers from various disciplines, covering a wide range of health 
conditions and illnesses, offer prodigious support for the use of the Health Belief Model. 
This model is appropriate as a theoretical basis for this research study on the educational 
and physical barriers to elderly patient adherence to prescribed ocular therapy.  
Social Cognitive Theory. The Social Cognitive Theory is a pivotal health 
education theory reflected throughout the literature reviewed for this research study. This 
theory has been used in multiple research studies and in interventions and programs 
designed to mitigate the educational and physical barriers to elderly patient adherence to 
medications. It was evident this theory serves as an appropriate foundation to support this 
research study. Introduced in the 1980’s this theory has evolved in practice and grown in 
favor amongst numerous health education research studies. Bandura (1988, p.276) 
 12 
 
presented the Social Cognitive Theory as, “a causal model where behavior, cognitive, and 
other personal factors, and environmental events all operate as interacting determinates 
that influence each other bi-directionally.” The Social Cognitive Theory and its focus on 
determinant factors was an evident choice for researchers investigating influencing 
factors on patient health behaviors.  Examining these factors helped researchers 
understand why non-adherence behaviors are observed. 
This literature review discovered subsequent studies continued to rely on the 
Social Cognitive Theory. Over a decade later, Bandura (2001, p.4) expanded upon the 
Social Cognitive Theory by stating “these belief systems are a working model of the 
world that enables people to achieve desired outcomes and avoid untoward ones.” 
Research about the educational and physical barriers are individualized exercises that 
impact patient adherence rates. Findings from this literature review helped to understand 
how these barriers play an important role in these cognitive self-regulatory processes. In 
the seminal study titled, “Patients' Beliefs about Prescribed Medicines and their Role in 
Adherence to Treatment in Chronic Physical Illness,” Horne and Weinman (1999, p.560) 
reported, “a relationship exists regarding patient beliefs about medicines to reported 
adherence rates.” Higher necessity scores were linked with higher reported adherence 
rates and higher concerns were linked to lower reported adherence rates. Longevity and 
reliability is key to substantiating the use of this theory in health education research 
studies related to the educational and physical barriers impacting elderly patient 
adherence. 
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Self-administering Medication in Elderly Patient Populations 
Historical vantage points: patient-centered, provider- centered, and 
concordance. Self-administering medication is a complex patient behavior. This 
literature review found that studies are replete with attempts to observe, measure, or 
explain this behavior. Until the philosophy of concordance arose in the early 2000’s there 
was compliance and adherence to medications. Horne et al. (2005) describe two primary 
vantage points found in the literature regarding the centricity of medication taking. These 
vantage points are from the perspectives of the patient or the provider. 
The term compliance has been used to describe the action of taking medication as 
prescribed by the health care provider. However, the literature revealed that it is a 
controversial term. Compliance suggests the patient is a passive responder to the 
provider’s directions. Vlasnik, Aliotta, and DeLor (2005, p.48) explain this perspective 
as, “adherence, formerly referred to as compliance, is a patient-centered term. It suggests 
that patients carry out and maintain certain behaviors, such as taking medications, after 
making an informed choice in a supportive environment.” Studies that focus primarily on 
patient centricity, medication taking is in essence administering prescribed ocular 
pharmaceuticals as instructed by the healthcare provider.  
In contrast to patient centered research, is medication adherence from the 
provider’s vantage. Adherence is considered a more suitable term because it recognizes 
the patient as autonomous in their self-administration of medication. It also requires the 
patient to agree to the directions given to them from the health care provider, by 
recognizing the provider as having a larger role in the success or failure of a prescribed 
ocular pharmaceutical therapy. The American College of Preventative Medicine (2011) 
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suggests provider discussions help patients understand their illness and weigh the risks 
and benefits of undergoing pharmaceutical treatment. Handbooks reviewed in this 
literature review include, Medication Management of the Community-Dwelling Older 
Adult. Patient Safety and Quality: An Evidence-Based Handbook for Nurses and Eye 
Drop Adherence: Waste, Contamination, Inaccuracy’s Pharmacist’s Guide; which 
demonstrated this perspective by delineating the roles and responsibilities of the eye care 
provider when discussing pharmaceutical therapy plans.  
Evolving from the compliance and adherence vantages of medication taking is the 
philosophy of concordance. A formative work that addresses the provider and patient 
relationship comes from Hughes (2004, p. 794), “Concordance represents a way in which 
[the patient] can assume responsibility and contribute to decisions on healthcare, 
particularly in relation to medications.” This can be thought of as a therapeutic agreement 
between the patient and health care provider. Dowell, Jones, and Snadden (2002, p.31) 
suggest that this “type of patient centered prescribing, focused on patients whose care is 
sub-optimal, is likely to improve clinical outcomes as well as diffuse the issue of 
adherence.” This literature review observed in the more recent studies that concordance is 
the predominant vantage for focusing on the factors and / or barriers that impact patients 
self-administering medication. 
Despite the progression of medication adherence from a single perspective to a 
collaborative one, medication adherence rates have remained stagnant. As reported by the 
American College of Preventative Medicine (2011), rates of adherence have not changed 
much in the last three decades, despite pushes from the World Health Organization 
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(WHO) and Institute of Medicine (IOM) improvement goals. 
Dimensions of medication adherence. A majority of the studies reviewed in this 
literature review agreed upon the use of the World Health Organization’s five interacting 
dimensions of medication adherence. Introduced in 2003, these dimensions include 1) 
social/economic factors, 2) healthcare system, 3) medical condition-related factors, 4) 
therapy-related factors, and 5) patient behaviors. The American Society on Aging and 
American Society of Consultant Pharmacists Foundation (2006) addressed how these five 
dimensions affect medication adherence. (See Figure 2.1.).  In summary of these 
dimensions, social and economic factors influence people to consider conflicting 
priorities. Healthcare system factors affect knowledge, training and performance of the 
health care team that includes the provider and patient as part of the system. Condition 
related factors represent illness-related demands experienced by the patient. Therapy 
related factors are unique characteristics of diseases and/or therapies. Patient behavior 
factors consider physical factors, such as visual impairment and impaired dexterity, as 
well as the resources, knowledge, attitudes, beliefs, perceptions and expectations of the 
patient. The factors applicable to each dimension and can be translated to perceived 
educational and physical barriers to using ocular pharmaceuticals. 
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Figure 2.1. The five dimensions of medication adherence listing factors within 
each dimension reported to affect adherence. From “Overview. Medication 
Adherence- Where Are We Today?” by American Society on Aging and 
American Society of Consultant Pharmacists Foundation, 2006, Adult 
Meducation. Improving Medication Adherence in Older Adults, p. 13. 
Copyright 2006 American Society on Aging and American Society of 
Consultant Pharmacists Foundation. 
 
 
Figure 2.1. Five Dimensions of Medication Adherence 
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It is important to note that not every factor indicated was applicable to this 
research study. A patient may have several risk factors for medication non-adherence and 
that each dimension may impact the patient more or less severely than another dimension.  
Self-administration. Many factors are considered for patients who are self-
administering their own eye drops to be considered adherent to their therapy. Non-
adherence to medication can be considered either willful or inadvertent. There is a long 
list of behaviors that account for non- adherence to medications. Exhibiting just one of 
the following behaviors from this list considers the patient as non-adherent. The 
American Society on Aging and American Society of Consultant Pharmacists Foundation 
(2006) assembled a common list of behaviors associated with elderly patients. These 
behaviors are applicable to drug classes, including eye drops: 
• Failing to initially fill a prescription 
• Failing to refill a prescription as directed 
• Omitting a dose or doses 
• Taking more or less of a medication than prescribed 
• Prematurely discontinuing medication 
• Taking a dose at the wrong time 
• Taking a medication prescribed for someone else 
• Taking a dose with prohibited other medications 
• Taking outdated medications 
• Taking damaged medications 
• Storing medications improperly 
• Using medication administration devices improperly 
 
Predictors of non-adherence. Elderly patients' non-adherence to medication 
regimens has the potential for negative health outcomes and far-reaching medical and 
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economic consequences. As Balkrishnan (1998, p.764) discussed, “as average life 
expectancy increases, so do the incidence of chronic diseases and the number of persons 
receiving long-term drug therapy.” Therefore preventing non-adherent behaviors is 
important in the design of medication-management programs for this population. 
Davis et al. (2006, p.849) recommends, “identification of older persons at risk for 
medication non-adherence is just the first step in addressing this problem.” There are 
warning signs of non-adherent behaviors of which healthcare providers and educators 
must understand and be aware. Ho, Bryson, and Rumsfeld (2009) describe this awareness 
and observation, although insensitive, of patient self-report of non-adherence is specific 
enough and can predict future adverse outcomes. These signs of non-adherent behaviors 
may not be obvious and health educators must be attentive to these signs. 
Touchette and Shapiro (2008) identified common risk factors for poor medication 
adherence, these are similar to risk factors reported by studies reviewed in this chapter 
and listed as follows: 
Educational predictors: 
• Low or limited language proficiency 
• Lack of belief in benefit of treatment 
• Inadequate follow-up or discharge therapy planning 
• Complexity of medication regimen 
• Side effects or fear of adverse reaction 
• Lack of insight into illness 
Physical predictors: 
• Lower cognitive function 
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• Impaired physical limitation 
• Reduced dexterity 
• Substance abuse 
Recommendations for study gaps 
It is evident that medication adherence is a complex behavior that is strongly 
influenced by multiple dimensions. The World Health Organization, (2003) suggests 
medication adherence is related to patient knowledge and beliefs about their illness, 
motivation to manage it, confidence in their ability to engage in illness-management 
behaviors, and expectations regarding the outcome of treatment and the consequences of 
poor adherence. Therefore, researchers would expect these influencing factors impacting 
patient’s medication-taking behavior to change over time.  
Two recommendations became apparent during this literature review; the need to 
conduct multiple medication adherence assessments and to standardize the measurements 
used in the assessment tools. Lee, et al. (2007) saw temporal changes in adherence 
measures when assessed using general linear models for repeated measures. This study 
highlights routine adherence assessments throughout a course of therapy. 
Recommendations for future research to standardize medication adherence measurements 
was suggested by multiple studies and emphasized by Morisky, Ang, Krousel-­‐‑Wood, and 
Ward (2008, p.348) who endorse this as a need for an “out-patient clinical settings need 
for a valid, reliable, cost-effective tool that is accepted by both health care providers and 
patients for measuring medication adherence.” For a better understanding of the 
significance of medication non-adherence, future research should focus on these 
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recommendations to standardize medication adherence measurements and use a 
standardized assessment tool among the elderly.  
Educational Barriers 
Studies were reviewed for identification of educational barriers related to elderly 
patients using eye drops as part of their ocular pharmaceutical treatment. This review 
included a search of research and literature that focused on components including health 
literacy, lack of language proficiency, and unproductive provider/patient communication 
methods. Educational barriers to understanding how to correctly use medications as 
prescribed by health care providers are a continuing problem facing patients, providers, 
and health educators. Health literacy is a known issue, as Nkukuma Ngoh (2009, p.132) 
states, “limited health literacy has been associated with poorer health, medication non- 
adherence, medication errors, higher medical expenses, and increased hospitalization.” 
Similar observations were reported and reinforced these factors as a component of 
educational barriers. Educational barriers negatively impact use of ocular 
pharmaceuticals. Low literacy rates and a lack of language proficiency were identified as 
predictors of medication non-adherence. 
A review of the available literature reveals a minimal number of studies have 
been conducted specifically on the impact of poor health literacy, lack of language 
proficiency, and provider/patient communication methods for ocular pharmaceutical 
therapy. Clifford, Barber, Elliott, Hartley, and Horne (2006) discuss the benefits from 
improved communication when pharmacists are meeting patients’ needs for information 
and advice on medicines. Seven studies identified in this review addressed educational 
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barriers to glaucoma therapy.  There is a lack of studies on educational barriers applicable 
to eye drops in ocular pharmaceutical therapy outside of glaucoma-specified conditions. 
A majority of studies reviewed for educational barriers that impact elderly patient 
medication adherence relied on qualitative research methods to gather information on eye 
drop users. The most commonly used tools were surveys, questionnaires, and in-depth 
interviews. For a majority of tools used to measure adherence Garber, Nau, Erickson, 
Aikens, and Lawrence (2004, p.649) suggest, “Questionnaires and diaries tend to have 
moderate-to-high concordance with other measures of medication adherence.” However, 
interview-based self-reports are not concordant with electronic measures. This 
inconsistency found in assessment measurement was a common occurrence amongst 
studies reviewed. 
Similar analysis techniques were applied by studies assessing educational barriers. 
The reported measurements were variable and unequivocal, thus making it incredibly 
difficult to compare results from multiple studies. Hess, Raebel, Conner, and Malone 
(2006) discussed how many measures used to assess adherence may or may not be 
comparable or accurate. Not having a standardized measure or scale is a predicament 
when trying to argue the importance of educational barriers. This is a discrepancy that 
studies focused on performing systematic reviews stated needing to be addressed. 
However, no study was identified having actually attempted to establish standardized 
measurement for comparing the various studies. 
The statistical results of research studies on educational barriers did not 
demonstrate a range of values. Effect size of education barriers reported by various 
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studies on the adherence rates was consistent. Peterson, Takiya, and Finley (2003) 
indicate interventions focused on education barriers had an overall effect size effect size 
of 0.11. The reported size effect of education barriers indicated no differences among the 
different types of educational interventions researched.  
Emerging from this review of available literature and studies on educational 
barriers were recommendations for mitigation. Several studies suggested development of 
a medication adherence model to guide healthcare providers. According to National 
Council on Patient Information and Education (2007, p.1) “to achieve the awareness, 
behavior changes, and additional resources for research and education that will improve 
patient medication adherence requires an ongoing partnership.” The purpose of 
developing a medication adherence model is to reduce the impact of education barriers on 
patient adherence to ocular pharmaceuticals. There is advocacy for educational strategies 
focused on patient behaviors. Addressing educational barriers through opportunities to 
engage providers and patients is a two- pronged approach to improving medication 
adherence. This review of the professional literature observed the Medication Adherence 
Model and the SIMPLE method as two influential works prominent in discussions 
regarding educational barriers. 
The Medication Adherence Model was developed to describe the process of 
medication adherence and instruct health care providers in a systematic method of 
assessing medication taking. Johnson (2002) suggests the model is structured with the 
idea that two types of non-adherence contribute to inconsistent medication taking. The 
first type of non-adherence is the intentional decision to miss medications. The second 
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type is unintentional interruptions that cause medications not to be taken. This model 
allows providers with an opening to evaluate these two types of non-adherence. Providers 
could also measure significance and overall effect of education barriers on ocular 
pharmaceutical adherence. Providers can parlay the results and use them in the treatment 
plan. These two types on non-adherence factors are employable as measurable indicators 
of ocular pharmaceutical adherence. 
The SIMPLE method is an educational strategy to improve medication adherence. 
According to Atreja et al. (2005, p. 4) it stands for S-simplify regimen, I-impart 
knowledge, M-modify patient beliefs and human behavior, P-provide communication and 
trust, L-leave the bias, and E-evaluate adherence. There is an abundance of support 
behind the SIMPLE method because it focuses on patient education. However, the 
method recognizes that education strategies must be paired with a simple regimen and 
effective provider/patient communication to modify medication adherence behaviors. 
This prominent study recommended promising strategies for providers and for patients to 
alleviate educational barriers. 
Physical Barriers 
This literature review found few research studies that focused on addressing 
physical barriers and how patients perceive physical capability as a function of adherence 
to therapy. Winfield, Jessiman, Williams, and Esakowitz (1990) explain their results 
indicated a high prevalence of non-compliance was compounded by inabilities to 
adequately instill a drop into the eye. Studies dedicated exclusively to researching 
physical barriers to ocular pharmaceutical instillation were few. Physical factors are a 
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patient related dimension of patient adherence. Examples of physical components that are 
barriers to correctly instilling eye drops are vision loss, cognitive ability, and factors such 
as impaired mobility or dexterity. 
Studies reviewed noted safety issues associated with vision loss. Low vision and 
blindness affect a person's ability to read prescription labels and information sheets about 
medications, distinguish colors and markings identifying a medication, and see 
measurement gauges on devices and tools. Elderly patients who cannot see and read 
prescription labels must rely on memory when self-administering eye drops. A physical 
risk for patients with low vision or vision loss is a physical condition. These are physical 
barriers for patients not taking their medications correctly or at all. 
Cognitive factors include physical and neurological impairment components such 
as memory loss. Salzman (1995) noted that forgetting to take a medication is a common 
problem in older people. This is reported as the most common barrier hindering the 
elderly when taking medications. Not instilling ocular pharmaceuticals correctly and 
timely due to forgetfulness is a non-adherent behavior associated with physical barriers. 
The last physical barrier related to elderly patients adherence to their ocular 
therapy is impaired motility and dexterity. These are specific physical barriers that may 
make it difficult for a patient to accurately instill or measure a dose. In the case of ocular 
pharmaceutics, a patient with impaired mobility or dexterity may be unable to position 
the eye dropper tip, apply enough pressure to the container to expel an eye drop, or instill 
the eye drop with enough precision into the eye’s conjunctiva sac.  
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The small portion of studies in this literature review that focused on physical 
barriers relied on qualitative research techniques to gather information on eye drop users. 
The studies assessing this barrier used similar instruments to collect data. Surveys, 
questionnaires, and observing instillation demonstrations were the main qualitative 
research instruments reported in the available studies.  
Researchers from studies available applied similar analysis techniques to assess 
the impact of physical barriers on eye drop medication adherence. The reported 
measurements were variable and unequivocal, thus making it very difficult to compare 
results from one study to another. Similar to studies on education barriers, not having a 
standardized measure or scale is a quandary. Health educators need reliable 
measurements to emphasize the importance of minimizing physical barriers. The 
literature reveals studies focused on performing systematic reviews have acknowledged 
this discrepancy in reported measurements. To date, no study has tried to establish a 
standardized measurement guideline for evaluating physical barriers.  
The statistical analysis of data on physical barriers demonstrated a stronger effect 
size on medication adherence. Morisky, Green, and Levine (1986) reviewed the 
psychometric properties to test the concurrent and predictive validity of a structured four-
item self-reported adherence measure. Items in this scale address physical barriers to 
medication taking, however, the scale is not specific to ocular pharmaceuticals. A 
stronger measure warrants the health care provider to reinforce positive medication 
adherence behaviors. However, with so few studies to report findings of the effect of 
physical barriers on medication adherence, there is a problem due to this lack of support 
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for a consensus of statistical significance.  
In the literature reviewed, three types of recommendations were found to help 
elderly patients overcome physical barriers and instill eye drops. This was emphasized by 
Tsai, Robin, and Smith (2007, p.29) as “an important factor that is often overlooked is the 
method of eye drop administration, including the handling, storing, and actual 
administering of eye drops.” Strategies for minimizing physical barriers involve self-
administering eye drops in optimal environmental conditions, the use of alternative label 
formats for elderly persons with visual impairment and the use devices to improve 
patients physical capability to instill the correctly into the conjunctiva sac with the correct 
number of drops and accurate dosage. 
Optimal physical environment that promotes accurate medication use include five 
key areas—1) illumination, 2) minimizing interruptions and distractions, 3) reducing 
sound and noise, 4) considering physical design and organization, and 5) designating 
medication safety zones. These ideal environmental conditions are recommended by 
Grissinger (2012) to minimize distractions for an elderly patient. When possible 
instillation should be performed in ideal settings that accommodate these five key areas 
conducive to correct eye drop instillation. 
The American Society on Aging and American Society of Consultant Pharmacists 
Foundation (2006) recommends the use of alternative label formats and devices for 
elderly persons with visual impairment to help overcome physical barriers. 
Recommendations from the American Society on Aging and American Society of 
Consultant Pharmacists Foundation (2006) also include: 
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o Asking the person if he or she needs help and what would be useful 
o Using large print on labels and written materials (minimum 16 point) 
o Using black ink on light background (high contrast) for written materials 
o Avoiding materials that reflect light or cause glare 
o Providing large print duplicate prescription label 
o Giving clear verbal instructions 
o Using color coding on medication containers (if patient can detect color) or 
different color labels on the bottles to indicate when to take medications 
o Using electronic dispensing devices with an alarm when dose is due 
o Using magnifying device 
o Encouraging improved lighting where medications are stored and taken 
o Using aids or tools to assist in instilling ocular pharmaceuticals (American 
Society on Aging and American Society of Consultant Pharmacists Foundation, 
2006). 
The use of mechanical aids can be helpful to elderly patients to overcome 
physical barriers to instilling eye drops. These devices are designed to assist the patient 
overcome various physical barriers. Corlett (1996) described the following trade-name 
eye drop devices: Opticare, Autosqueeze, and Autodrop. Eye drop devices aid in 
positioning the eye drop, so instillation is performed correctly. The eyedropper tip is 
aimed with precision into the conjunctiva sac. Additionally, these aids help to enhance 
the physical strength of a patient to squeeze the correct size eye drop from the bottle. 
Drop size is important because too large or small of a drop is a variability in dosage.  
 28 
 
Gaps in the Literature 
Three main gaps were found in the literature available on education and physical 
behaviors that impact elderly patient adherence to ocular pharmaceutics. The available 
studies in this literature review did not explain in great detail these potential barriers to 
medication adherence. They did not necessarily focused on patients undergoing ocular 
pharmaceutical treatment. Lastly, there was a clear limitation of the data available. 
Although there is a moderate amount of information and research completed on 
medication adherence, these particular barriers to correct usage are not well described. 
Gellad, Grenard, andMarcum (2011, p.11) summarized this observation well, 
“medication non-adherence in the elderly is not well described in the literature, despite 
being a major cause of morbidity, and thus it is difficult to draw a systematic conclusion 
on potential barriers based on the current literature.” Most of the recent studies 
recommend further research or investigation into the additional potential factors that 
contribute to education or physical barriers. However, to date, this literature review found 
the education and physical barriers impacting the dimensions of medication adherence 
under-evaluated. 
In addition to detecting studies that under-evaluated barriers to medication 
adherence, only two studies actually recommended findings that were translational to 
ocular pharmaceuticals. Notably, most of the studies related to ocular pharmaceuticals 
were tied to glaucoma diagnosis and therapy. This literature review found seven studies 
focused on ocular pharmaceutical treatments for glaucoma. A total of five studies focused 
specifically of educational or physical barriers and the impact on patient medication 
adherence to ocular pharmaceutical therapy. This literature review search found three 
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studies focused explicitly on education barriers to patient adherence to ocular 
pharmaceutical therapy. Only two studies focused on exactly on the physical barriers 
impacting patient adherence to ocular pharmaceutical therapy. This scarce number of 
available studies demonstrated just how under-evaluated this class of pharmaceuticals is 
in health education literature. 
The data available, through literature database searches, for this literature review 
was also limited. In order to assess the available literature for the research questions 
required independent searches of the key words: elderly patients, medication adherence, 
educational and physical barriers, and ocular pharmaceuticals. Refining the database 
search to find studies that focused explicitly on the research questions required connected 
searches (linked Boolean method) of these same key words. The databases searched 
included Ageline, BioMedCentral, Cochrane Plus Collection, MEDLINE, and 
ScienceDirect. This literature review revealed that very limited data has been collected 
that comprehensively addressed elderly patients, medication adherence, educational and 
physical barriers, and ocular pharmaceuticals. Inadequate available data collected on 
ocular pharmaceutical therapy was an issue. Mojtabai and Olfson (2003, p.228) highlight 
the problem with limited data and argued that, “despite widespread public attention to 
this issue, little information exists concerning the use of medications and health outcomes 
among Medicare beneficiaries without prescription drug coverage.” Data on elderly 
patients relies heavily on prescription claims data. In the United States potential sources 
of raw medication data comes from Medicare information. A majority of the studies 
reviewed collected data from surveys, interviews, and interventions, but also made use of 
claims data, referenced in their methodology. 
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Summary 
Low medication adherence rates to ocular pharmaceuticals continue to be a 
problem in health education. The historical perspectives of medication taking were either 
from a patient-centered vantage or a provider vantage point. Perspectives then 
transitioned the focus of medicine taking from compliance, to adherence, and most 
recently concordance. More recent studies focus on concordance, where a patient and 
provider agreement on ocular pharmaceutical therapy. This integrative literature review 
considered the available works and selected featured studies and key research conducted 
on elderly patient adherence to instilling ocular pharmaceutical medication.  
The emphasis of this review was on the impact of educational and physical 
barriers to correct eye drop instillation in elderly populations. Educational and physical 
barriers played a large part in patient adherence to their prescribed ocular pharmaceutical 
therapy. This review of related literature describes how previous and current studies have 
investigated the problem of educational and physical barriers and evaluates programs for 
their success or failure in improving patient adherence rates. Educational 
recommendations aligned with these by Okeke, et al. (2009) are understanding 
educational efforts to improve patient drop taking played an important role in improving 
patient adherence. These included instruction on proper administration of eye drops, 
correct dosing schedules, minimization of waste of medication, and a clear discussion 
that vision can be lost if the medications are not used properly. Strategies to minimize 
education barriers integrates an agreed upon provider/patient ocular pharmaceutical 
therapy. The strategies include a two pronged approached to address health literacy and 
lack of language proficiency. Suggestions from studies reviewed to lessen the negative 
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impact of physical barriers such as Lacey, Cate, and Broadway (2009) emphasized 
common recommendations to improve the operational and technique issues as the main 
areas of physical barrier concerns to mediation adherence. These recommendations 
included optimizing environmental conditions, advocating for alternative label formats, 
and suggesting the use of eye drop instillation tools or aids to express eye drop solution 
into the eye. For both education and physical barriers standardized measurement is 
encouraged to increase validity and reliability of patient adherence assessments. 
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Chapter III: Methodology 
Introduction 
The purpose of this research was to assess and evaluate elderly patients’ attitudes 
and behavior about educational and physical barriers and the impact on adherence to 
ocular pharmaceuticals. This chapter describes the research design of this study and 
selection of eligible participants, survey instrument, data collection, data analysis, and 
pilot test used to gather data. The Minnesota State University, Mankato Institutional 
Review Board (IRB) was approved the study proposal on February 24, 2015. (See 
Appendix B). 
Research Questions 
1. For elderly patients, how can the educational barrier of a lack of understanding of 
how to properly instill ocular pharmaceuticals be addressed and improved upon?  
2. For elderly patients, how can physical barriers be addressed to improve the ability 
to properly self-administer eye drops as prescribed? 
Research Design 
This thesis research is designed as a one-time cross sectional study. The 
methodologies employed are quantitative research techniques. Data were collected using 
a survey instrument that included an open response portion to three questions. The 
following sections describe the methods selected for inclusion criteria, instrumentation, 
and procedure. Descriptions of the qualitative and statistical analysis for this research 
study are also included. 
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Inclusion criteria. Inclusion criteria for participants in this study were very 
particular. To address how educational and physical barriers impact patient adherence to 
eye drops requires specific criteria based upon age, diagnosis, and treatment. The 
inclusion criteria for this research study are: 
1. The participant must be aged 65 years or older. 
2. The participant must be diagnosed with an eye disease, condition, or illness. 
3. The participant is currently under going ocular pharmaceutical treatment with eye 
drops at the time of data collection. 
This research study used homogenous sampling procedures to find participants for 
this study population. According to Cottrell and McKenzie (2011, p.132) homogenous 
sampling procedures “includes individuals chosen because of a unique trait or factor they 
posses.” The unique trait in this study is a participant is selected because she/he possesses 
a unique diagnosis requiring treatment with eye drops. Homogenous sampling procedure 
is appropriate for this study because of the difficulty in identifying participants with a 
specific health condition and treatment approach and identifying an acceptable number of 
eligible participants.  
Instrument consideration. When studying subjects who are currently 
undergoing ocular pharmaceutical therapy, the survey instrument must consider 
addressing areas of concerns that include private health information and confidentiality. 
The in-person and online consent forms explained the purpose of this study and a form 
was included with every survey instrument. (See Appendix C and Appendix D). To 
safeguard the patient’s private heath information and confidentiality, participants are not 
asked to include their name on the survey instrument. Additionally, the survey does not 
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focus on demographic questions that could identify a participant. The two demographic 
questions included in the survey instrument are participant age and gender.  
Instrument design.  Instrument design required incorporating the participant 
inclusion criteria questions into the survey. This allows the researchers to easily identify 
which participants were eligible. Using inclusion criteria as survey questions ensures the 
data collected is relevant to answering the questions asked in this study. 
The survey instrument format began with a statutory question set that included 
general demographic questions and inclusion criteria questions. These statutory questions 
were designed to identify eligible participants. The survey questions focused on 
addressing the educational and physical barriers of instilling eye drops will collect data to 
support the operational constructs. These Likert-scale questions identify levels of 
agreement about educational and physical barriers. The survey instrument format ended 
with open-response questions. This question type provided participants with an 
opportunity to share qualitative details regarding their ocular pharmaceutical experience. 
 The survey instrument design utilized statutory, Likert-scale, and open response 
questions to gather a wide breadth of data. Data collected from this instrument are 
directly pertinent to the research questions and help in understanding the impact of 
educational and physical barriers on patient adherence to their prescribed eye drop 
therapy. 
Validity and Reliability 
Validity. The researcher developed the survey instrument for use in this thesis 
study. To ensure content validity of the survey instrument, the survey questions were 
written with the advisement of two pharmacist advisors. (See Appendix E). Conferring 
 35 
 
with professionals from the pharmaceutical field of work supports the validity of the 
survey questions. The survey questions were designed to gather information and data 
related to the research questions. This additionally ensured the questions were written 
with a pharmacy perspective and maintained the continuity of this thesis study within 
scope of ocular pharmaceutical therapy.  
Reliability. Reliability measures were integrated into the survey instrument. 
There is only one version of the survey instrument. Using only one version of the survey 
ensured each participant was exposed to the same questions. This addressed measurement 
consistency because using one version of the survey instrument elicited the same type of 
responses from the same questions.  
Pilot Test 
A group of four people who met inclusion criteria were asked by the student 
researcher to test the survey instrument. It was administered as described for in-person 
survey takers. The feedback collected was used to improve its design. Regarding the 
procedure the pilot test group made the recommendation that the researcher should be 
available for questions. An observation noted about survey administration was the time to 
complete the survey questions was actually less than the five minutes stated on the 
consent form. Feedback collected about the survey instrument was also gathered. The 
pilot test group recommended larger font. This recommendation was used and the survey 
font-size was increased. The pilot test group also suggested that the Likert-type 
education/instruction questions could be more concise. The changes collected from the 
pilot test group were incorporated in the final survey instrument used for this study. 
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Data Collection Process 
Research design description. This study used a conjugated research design to 
gather data and answer the two research questions. The design used both a quantitative 
and qualitative data collection techniques. The survey questions gathered responses from 
participants about their perception of educational and physical barriers. Participants could 
also provide responses regarding the impact of these barriers on their adherence to their 
prescribed ocular therapy. The narratives provided to the open response questions gave 
in-depth and detailed information about experiences and offered perspectives on 
undergoing prescribed ocular pharmaceutical therapy.  
Survey administration procedure. Prior to distributing the survey instrument, 
the researcher obtained approval from Minnesota State University, Mankato IRB to 
conduct research on human subjects. 
The survey instrument was distributed in-person and electronically. In-person 
events were conducted at local Minneapolis area senior centers. Written permission was 
granted by the Edina Senior Center (See Appendix F) and by the Burnsville Senior 
Center (See Appendix G). A table set up was arranged to offer the surveys to persons 
who visited the community center on March 3, 2015 and March 10, 2015. With each 
encounter, the researcher explained the purpose of the study before asking a person to 
take a survey. Before a survey was taken the consent form was offered. It was read aloud, 
when requested. Then a signature was collected prior to the survey questions being 
answered. When the participant completed the survey, it was collected and placed in an 
envelope. The researcher offered the participant a copy of the consent form. Lastly and 
equivocally important was that participants were thanked for their time. 
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Electronic distribution of the survey was conducted using the online survey 
administrative tool, Zoomerang ™. The researcher set up a user account with 
administrative rights that established distribution controls. These controls included 
defining the inclusion criteria to target eligible survey participants. Zoomerang ™ 
allowed the researcher to define who the potential respondents were by restricting the 
respondent pool. The criteria entered into the Zoomerang ™ database to target an 
audience for this survey were age and treatment. After the researcher defined the target 
audience, an electronic version of the consent form and survey was distributed to the 
target audience email lists. The respondents were required to indicate they had received 
the consent. Requiring the consent form to be acknowledged prior to beginning the actual 
survey is an administrative control. Another administrative control in place was the 
timeframe for administering and collecting surveys; approximately two-weeks between 
February 25, 2015 to March 11, 2015. As surveys were completed, Zoomerang ™ 
securely cached the surveys for the researcher. 
Analysis of Data 
The data analysis procedure used for this research study was descriptive statistics. 
Analysis of the quantitative data collected from the survey was completed using the SPSS 
analytical tool. The table of specifications lists how each survey question tied directly to 
the research questions asked in this thesis study. (See table 3.1). The research questions 
were designed to collect interval, nominal, and ordinal data. The data were analyzed with 
descriptive statistical analysis to evaluate the frequency and percentage of responses.  
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 Table 3.1  
Table of Specifications 
 
Research Question 
(RQ) 
Survey items or methods used 
to assess RQ’S 
Level of Data 
(Nominal, 
Ordinal, 
Interval/Ratio)* 
Analysis 
needed to 
assess RQ 
1. How can the 
educational 
barrier of a lack 
of understanding 
how to properly 
instill ocular 
pharmaceuticals 
be addressed and 
mitigated? 
 
What is your eye condition? Nominal Frequency, 
Percentage 
 How long have you been using 
eye drops to treat your eye 
condition? 
 
Interval Frequency, 
Percentage 
 How frequently do you see your 
Optometrist or Ophthalmologist? 
- Never    
- 1time each year 
- 2 to 3 times each year  
- More than 4 times each year 
 
Ordinal Frequency, 
Percentage 
 Who provides you with 
instructions on how to use your 
eye drops?  
- Optometrist or     
Ophthalmologist 
- General or Primary Physician 
- Physicians’ assistant 
- Nurse 
- Pharmacist 
- Other: Please, describe _____ 
- No one 
 
Nominal Frequency, 
Percentage 
 How many eye drops are lost 
and do not make it into your 
eye(s) per dose? 
- No drops are lost per dose 
- 1 to 2 drops are lost per dose 
- 3 to 4 drops are lost per dose 
- More than 5 drops are lost per 
dose 
 
Ordinal Frequency, 
Percentage 
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Table 3.1  
Table of Specifications 
 
   
 How many eye drops do you use 
to treat your eye condition? 
- One 
- Two 
- Three or more 
 
Ordinal Frequency, 
Percentage 
 How long have you been using 
your eye drops to treat your eye 
condition? 
- Less than 1 week 
- 1 to 2 weeks 
- 3 or more weeks 
 
 Frequency, 
Percentage 
 Instructions on how to use your 
eye drops are easy to follow. 
1- Strongly Agree 
2- Somewhat Agree 
3- Indifferent 
4- Somewhat 
Disagree 
5- Strongly Disagree 
 
Ordinal Frequency, 
Percentage 
 Word choice to explain 
instructions is clear to 
understand how to use your eye 
drops. 
1- Strongly Agree 
2- Somewhat Agree 
3- Indifferent 
4- Somewhat 
Disagree 
5- Strongly Disagree 
 
Ordinal Frequency, 
Percentage 
 Using pictures to illustrate 
instructions for how to use your 
eye drops would improve your 
understanding of how to use 
them. 
1- Strongly Agree 
2- Somewhat Agree 
3- Indifferent 
4- Somewhat 
Disagree 
5- Strongly Disagree 
 
Ordinal Frequency, 
Percentage 
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Table 3.1  
Table of Specifications 
 
   
 Using video instructions to 
demonstrate the instructions for 
how to use your eye drops would 
improve your understanding of 
how to use them. 
1- Strongly Agree 
2- Somewhat Agree 
3- Indifferent 
4- Somewhat 
Disagree 
5- Strongly Disagree 
 
Ordinal Frequency, 
Percentage 
 What do you believe are 
educational barriers to effective 
use? In your opinion, how could 
the instructions for your eye 
drops be improved? 
 
Ordinal- looking 
for themes 
Frequency, 
Percentage 
2. How can the 
physical barriers 
be addressed to 
improve the 
ability to 
properly instill 
prescribed eye 
drops? 
 How many eye drops are lost 
and do not make it into your 
eye(s) per dose? 
- No drops are lost per dose 
- 1 to 2 drops are lost per dose 
- 3 to 4 drops are lost per dose 
- More than 5 drops are lost per 
dose 
 
Ordinal Frequency, 
Percentage 
 Instructions in larger font would 
improve your ability to see and 
read the instructions clearly. 
1- Strongly Agree 
2- Somewhat Agree 
3- Indifferent 
4- Somewhat 
Disagree 
5- Strongly Disagree 
 
Ordinal Frequency, 
Percentage 
 Having your health care 
professional demonstrate how to 
properly use your eye drops 
would improve your ability to 
use them on your own. 
1- Strongly Agree 
2- Somewhat Agree 
3- Indifferent 
4- Somewhat 
Disagree 
5- Strongly Disagree 
 
Ordinal Frequency, 
Percentage 
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Table 3.1  
Table of Specifications 
 
   
 An eye drop dispenser tool 
would improve your ability to 
properly use your eye drops. 
1- Strongly Agree 
2- Somewhat Agree 
3- Indifferent 
4- Somewhat 
Disagree 
5- Strongly Disagree 
 
Ordinal Frequency, 
Percentage 
 Do you have a physical 
limitation that makes using eye 
drops difficult? Does this 
limitation require additional 
tools or devices to assist in using 
eye drops? 
 
Ordinal- looking 
for themes 
Frequency, 
Percentage 
 Does the location of where you 
instill eye drops (your 
environment) impact your ability 
to use them? 
 
Ordinal- looking 
for themes 
Frequency, 
Percentage 
* Indicates level of data for survey items or methods, not RQ’s 
 
 
To evaluate narrative responses from the open-response questions on the survey 
instrument this study used the ethnographic statistical procedure. According to Vinson 
(2012, p.1) the ethnographic method is “a data-driven method for analyzing real world 
observations provided by others.” The ethnographic statistical procedure was appropriate 
for this study because this procedure is more reliable for qualitative evaluation 
techniques. This procedure analyzes valid measures for population-defined constructs by 
identifying common themes shared among the responses to these open-response 
questions.  For this study, ethnographic procedure was used to make systematic 
observations from the narratives provided from the participants. Trends or themes 
observed in data collected are discussed in the following chapters. 
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Chapter IV: Findings 
Introduction 
The purpose of this research was to assess and evaluate elderly patients’ attitudes 
and behavior about educational and physical barriers and the impact on adherence to 
ocular pharmaceuticals. In order to collect data a 19 question survey was developed and 
administered in person at the Edina Senior Center and Burnsville Senior Center and 
online via Zoomerang ™ regarding attitudes on educational and physical barriers and 
their impact on ocular pharmaceutical adherence. The findings from the quantitative and 
qualitative analysis for each research question are presented in this chapter. 
Survey Responses 
After IRB approval was obtained, data collection occurred over a time frame of 
two weeks from February 25, 2015 to March 11, 2015. A total of 140 survey responses 
were collected for this research study. Sixteen of these surveys were collected from in-
person tabling events; six from the Edina Senior Center during a Bridge game night and 
10 from Burnsville Senior Center during a scheduled social painting event. The online 
survey was open and responses were collected for 14 days from February 25, 2015 to 
March 11, 2015. One hundred and twenty-four responses were collected electronically.  
Eligible Survey Responses 
Thirty-four survey responses collected were considered eligible for the scope of 
this research study. The respondents included in this analysis met the inclusion criteria of 
being 65 years of age or older, undergoing the treatment of an eye condition, and the use 
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of eye drops as part of their ocular pharmaceutical therapy. A flow chart for determining 
participant eligibility for this research study is presented in this chapter. (See Figure 4.1).  
Because of the design of this research study both quantitative and qualitative statistical 
analyses were used to answer the research questions. By completing the survey 
instrument and/or by signing the consent form, participants gave consent. Responses 
from the 34 eligible participants who met the inclusion criteria of being 65 years of age or 
older, treating an ocular condition, and using eye drops as part of their ocular therapy 
were coded and entered into a SPSS database for analysis. 
Ineligible Survey Responses 
One hundred and six survey responses were considered ineligible for the scope of 
this research study. Specifically, nine survey responses were excluded from analysis 
based upon age criteria because five respondents were less than 65 years of age, three 
respondents did not provide their age in years, and one respondent did not provide their 
age in an interpretable format. Additionally, seventy survey responses were excluded 
from analysis because the respondents indicated they were not being treated for an eye 
condition. Specifically, these respondents indicated ‘no’, ‘none, or ‘NA’ to this question 
and eight respondents did not provide a response or left this question blank. Of the 
respondents with an eye condition, twenty-seven respondents indicating their treatment 
did not include the use of eye drops as part of their therapy. 
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Respondents Demographics 
The demographic information obtained from this research study included the age 
and gender of the respondents. The median age of the eligible respondents is 69 years of 
age. The range of ages of the respondents is 65 years to 99 years. Demographic data 
revealed that 38.2% (n= 13) were male, 58.8% (n=20) were female, and 2.9% (n=1) did 
not indicate a gender.  
In order to identify selected elderly patients using ocular pharmaceuticals as part 
of their therapy, participants were asked to describe their ocular conditions. All 34 
participants responded to this question. This included identification with a singular ocular 
condition or multiple ocular conditions being treated with ocular pharmaceuticals. 36.6% 
(n = 15) identified as having dry eye, 19.5% (n = 8) identified as having Glaucoma, 
12.2% (n = 5) identified as having cataracts, 4.9% (n = 2) identified as having Macular 
Degeneration, 4.9% (n = 2) identified as having Allergies, 4.9% (n = 2) identified as 
having near-sightedness (myopia), 2.4% (= 1) identified as having sensitivity to light, 
2.4% (n= 1) identified as having stroke, 2.4% (n = 1) identified as having Strabismus, 
2.4% (n = 1) identified as having Shingles, 2.4% (n = 1) identified as having Sjogren’s 
Syndrome, and 2.4% (n = 1) identified as having to wear glasses. (See table 4.1.) 
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Table 4.1 
Ocular Conditions Reported by Elderly Patients Currently Being Treated with Ocular 
Pharmaceuticals 
Ocular 
Condition 
Male Female Gender Not 
Specified 
Frequency % 
Dry eyes 1 13 1 15 36.6 
Glaucoma 5 3 0 8 19.5 
Cataracts 4 1 0 5 12.2 
Macular 
Degeneration 
0 2 0 2 4.9 
Allergies 1 1 0 2 4.9 
Good 2 0 0 2 4.9 
Near-
sightedness 
(Myopia) 
 
0 2 0 2 4.9 
Sensitivity to       
light 
 
0 1 0 1 2.4 
Stroke 1 0 0 1 2.4 
Strabismus 1 0 0 1 2.4 
Shingles 1 0 0 1 2.4 
Sjogren’s 
Syndrome 
 
0 1 0 1 2.4 
Total 
Responses 
16 24 1 41 100 
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Research Question 1: For elderly patients, how can the educational barrier of 
a lack of understanding how to properly instill ocular pharmaceuticals be addressed 
and mitigated? 
In order to understand how the educational barrier of a lack of understanding how 
to properly instill ocular pharmaceuticals can be addressed and mitigated; participants 
were asked to designate the frequency of visits to an optometrist or ophthalmologist. All 
34 participants provided a response; 2.9% (n = 1) participants reported they never made a 
visit to their optometrist or ophthalmologist, 44.1% (n = 15) reported they visit their 
optometrist or ophthalmologist 1 time each year, 38.2% (n = 13) reported they visit their 
optometrist or ophthalmologist 2 to 3 times each year, and 14.7% (n = 5) reported they 
visit their optometrist or ophthalmologist more than 4 times each year. (See table 4.2). 
Table 4.2 
Frequency of Visits to an Optometrist or Ophthalmologist as Reported by Elderly 
Patients Currently Being Treated with Ocular Pharmaceuticals 
Responses Male Female Gender Not 
Specified 
Frequency % 
Never 1 0 0 1 2.9 
1 time each 
year 
4 11 0 15 44.1 
2 to 3 times 
each year 
 
6 7 0 13 38.2 
More than 4 
times each 
year 
 
2 2 1 5 14.7 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to indicate the healthcare professional who provided their 
instructions for ocular pharmaceuticals. All 34 participants provided a response; 73.5% (n 
= 25) reported Optometrists or Ophthalmologist, 5.9% (n = 2) reported General or 
Primary Physician, 2.9% (n = 1) reported Nurse, 2.9% (n = 1) reported Pharmacist, 
11.8% (n = 4) reported No one, and 2.9% (n = 1) reported Self. (See table 4.3). 
 
Table 4.3 
Health Care Professional Who Provide Ocular Pharmaceutical Instructions as Reported 
by Elderly Patients Currently Being Treated with Ocular Pharmaceuticals 
Responses Male Female Gender Not 
Specified 
Frequency % 
Optometrist or 
Ophthalmologists 
 
10 14 1 24 73.5 
General or 
Primary 
Physician 
 
1 1 0 2 5.9 
Nurse 0 1 0 1 2.9 
Pharmacist 0 1 0 1 2.9 
No One 1 3 0 4 11.8 
Self 1 0 0 1 2.9 
Total Responses 13 20 1 34 100 
  
 49 
 
Participants were asked to denote the number of ocular pharmaceuticals they are 
using as part of ocular treatment. All 34 participants provided a response; 70.6% (n = 24) 
reported using one ocular pharmaceutical, 23.5% (n = 8) reported using two ocular 
pharmaceuticals, and 5.9% (n = 2) reported using three or more ocular pharmaceuticals. 
(See table 4.4). 
 
Table 4.4 
Number of Ocular Pharmaceuticals Used in Ocular Treatment as Reported by Elderly 
Patients Currently Being Treated with Ocular Pharmaceuticals 
Responses Male Female Gender Not 
Specified 
Frequency % 
One 
 
9 15 0 24 70.6 
Two 
 
3 5 0 8 23.5 
Three or more 1 0 1 2 5.9 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to denote the duration of their ocular therapy. All 34 
participants provided a response; 0.0% (n = 0) reported therapy lasting less than 1 week, 
8.8% (n = 3) reported 1 to 2 weeks, and 91.2% (n = 31) reported three or more weeks. 
(See table 4.5). 
 
Table 4.5 
Duration of Ocular Therapy as Reported by Elderly Patients Currently Being Treated 
with Ocular Pharmaceuticals 
Responses Male Female Gender Not 
Specified 
Frequency % 
Less than 1 
week 
 
0 0 0 0 0.0 
1 to 2 weeks 
 
2 1 0 3 8.8 
3 or more 
weeks 
11 19 1 31 91.2 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to indicate the number of eye drops lost and did not make 
it into the eye(s) per dose when used in ocular treatment. All 34 participants provided a 
response; 47.1% (n = 16) reported no drops, 47.1% (n = 16) reported 1 to 2 drops, 2.9 % 
(n = 1) reported 3 to 4 drops, and 2.9 % (n = 1) reported more than 5 drops. (See table 
4.6). 
 
Table 4.6 
Number of Eye Drops Lost and Did Not Make It in to the Eye (s) Per Dose When Used in 
Ocular Treatment as Reported by Elderly Patients Currently Being Treated with Ocular 
Pharmaceuticals 
Responses Male Female Gender Not 
Specified 
Frequency % 
No drops 
 
8 8 0 16 47.1 
1 to 2 drops 
 
5 11 0 16 47.1 
3 to 4 drops 0 0 1 1 2.9 
More than 5 
drops 
 
0 1 0 1 2.9 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to indicate their agreement with the statement, 
“Instructions on the eye drop box are clear and easy to understand.” All 34 participants 
responded to this question; 61.8% (n = 21) reported strongly agree, 23.5% (n = 8) 
reported somewhat agree, 8.8% (n = 3) reported indifferent, 2.9% (n = 1) reported 
somewhat disagree, and 2.9% (n = 1) reported strongly disagree. (See table 4.7). 
 
Table 4.7 
Instructions on the eye drop box are clear and easy to understand 
Responses Male Female Gender Not 
Specified 
Frequency % 
Strongly Agree 
 
7 13 1 21 61.8 
Somewhat 
Agree 
 
3 5 0 8 23.5 
Indifferent 
 
1 2 0 3 8.8 
Somewhat 
Disagree 
 
1 0 0 1 2.9 
Strongly 
Disagree 
 
1 0 0 1 2.9 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to indicate their agreement with the statement, “Word 
choice to explain instructions is clear to understand how to use your eye drops.” All 34 
participants responded to this question; 67.6% (n = 23) reported strongly agree, 17.6% (n 
= 6) reported somewhat agree, 11.7% (n = 4) reported indifferent, 2.9% (n = 1) reported 
somewhat disagree, and 0.0% (n  = 0) reported strongly disagree. (See table 4.8). 
 
Table 4.8 
Word choice to explain instructions is clear to understand how to use your eye drops 
Responses Male Female Gender Not 
Specified 
Frequency % 
Strongly Agree 
 
7 15 1 23 67.6 
Somewhat 
Agree 
 
3 3 0 6 17.6 
Indifferent 
 
2 2 0 4 11.7 
Somewhat 
Disagree 
 
1 0 0 1 2.9 
Strongly 
Disagree 
 
0 0 0 0 0.0 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to indicate their agreement with the statement, “The use 
of pictures to illustrate would improve your understanding of the eye drop instructions.” 
All 34 participants responded to this question; 29.4% (n = 10) reported strongly agree, 
17.6% (n = 6) reported somewhat agree, 32.3% (n = 11) reported indifferent, 8.8% (n = 
3) reported somewhat disagree, and 11.8% (n = 4) reported strongly disagree. (See table 
4.9). 
 
Table 4.9 
The Use of Pictures to Illustrate Would Improve your Understanding of the Eye Drop 
Instructions 
Responses Male Female Gender Not 
Specified 
Frequency % 
Strongly Agree 
 
2 8 0 10 29.4 
Somewhat 
Agree 
 
2 4 0 6 17.6 
Indifferent 
 
6 4 1 11 32.3 
Somewhat 
Disagree 
 
1 2 0 3 8.8 
Strongly 
Disagree 
 
2 2 0 4 11.8 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to indicate their agreement with the statement, “The use 
of a video demonstration would improve your understanding of the eye drop 
instructions.” All 34 participants responded to this question; 17.6% (n = 6) reported 
strongly agree, 11.8% (n = 4) reported somewhat agree, 38.2% (n = 13) reported 
indifferent, 8.8% (n = 3) reported somewhat disagree, and 23.5% (n = 8) reported 
strongly disagree. (See table 4.10). 
 
Table 4.10 
The Use of a Video Demonstration Would Improve your Understanding of the Eye Drop 
Instructions 
Responses Male Female Gender Not 
Specified 
Frequency % 
Strongly Agree 
 
1 5 0 6 17.6 
Somewhat 
Agree 
 
2 2 0 4 11.8 
Indifferent 
 
6 6 1 13 38.2 
Somewhat 
Disagree 
 
1 2 0 3 8.8 
Strongly 
Disagree 
 
3 2 0 8 23.5 
Total 
Responses 
13 20 1 34 100 
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Open-Response Questions Addressing Educational Barriers 
Thirteen respondents did not elaborate or provide further detail on the open-
response survey questions. Detailed experiences provided by other participants hit keenly 
on key words and phrases. Ethnographic analysis of their experiences identified two main 
categories of eye drop users; experienced and inexperienced. Experienced users 
suggested instruction provided with or without provider interactions were clear and easy 
to understand. Inexperienced users highlighted instructional needs for first-time eye drop 
users. Notable suggestions from the participants also included recommendations for 
product and provider improvement.  It was recommended that ocular pharmaceutical 
could have dosage indicators on the products themselves and if instructional time with 
the provider could be increased.  
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Research Question 2: For elderly patients, how can physical barriers be 
addressed to improve the ability to properly self-administer eye drops as 
prescribed? 
In order to understand how physical barriers could be addressed to improve the 
ability to properly self-administer eye drops as prescribed; participants were asked to 
indicate their agreement with the statement, “Instructions in larger font would improve 
your ability to see and read the instructions clearly.” All 34 participants responded to this 
question; 58.8% (n = 20) reported strongly agree, 29.4% (n = 10) reported somewhat 
agree, 5.9% (n = 2) reported indifferent, 0.0% (n = 0) reported somewhat disagree, and 
5.9% (n = 2) reported strongly disagree. (See table 4.11). 
 
Table 4.11 
Instructions in Larger Font Would Improve your Ability to See and Read the Instructions 
Clearly 
Responses Male Female Gender Not 
Specified 
Frequency % 
Strongly Agree 
 
7 12 1 20 58.8 
Somewhat 
Agree 
 
5 5 0 10 29.4 
Indifferent 
 
1 1 0 2 5.9 
Somewhat 
Disagree 
 
0 0 0 0 0.0 
Strongly 
Disagree 
 
0 2 0 2 5.9 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to indicate their agreement with the statement; “Having 
your health care professional demonstrate how to properly use your eye drops would 
improve your ability to use eye drops on your own.” All 34 participants responded to this 
question; 38.2% (n = 13) reported strongly agree, 20.6% (n = 7) reported somewhat 
agree, 26.5% (n = 9) reported indifferent, 8.8% (n = 3) reported somewhat disagree, and 
5.9% (n = 2) reported strongly disagree. (See table 4.12). 
 
Table 4.12 
Having your Health Care Professional Demonstrate how to Properly Use your Eye 
Drops Would Improve your Ability to Use Eye Drops on your Own 
Responses Male Female Gender Not 
Specified 
Frequency % 
Strongly Agree 
 
5 7 1 13 38.2 
Somewhat 
Agree 
 
2 5 0 7 20.6 
Indifferent 
 
3 6 0 9 26.5 
Somewhat 
Disagree 
 
2 1 0 3 8.8 
Strongly 
Disagree 
 
1 1 0 2 5.9 
Total 
Responses 
13 20 1 34 100 
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Participants were asked to designate their agreement with the statement; “An eye 
drop dispenser tool would improve your ability to properly use your eye drops.” All 34 
participants responded to this question; 20.6% (n = 7) reported strongly agree, 29.4%    
(n = 10) reported somewhat agree, 32.4% (n = 11) reported indifferent, 11.8% (n = 4) 
reported somewhat disagree, and 5.9% (n = 2) reported strongly disagree. (See table 
4.13). 
 
Table 4.13 
An Eye Drop Dispenser Tool Would Improve your Ability to Properly Use your Eye 
Drops 
Responses Male Female Gender Not 
Specified 
Frequency % 
Strongly Agree 
 
2 5 0 7 20.6 
Somewhat 
Agree 
 
4 6 0 10 29.4 
Indifferent 
 
4 6 1 11 32.4 
Somewhat 
Disagree 
 
2 2 0 4 11.8 
Strongly 
Disagree 
 
1 1 0 2 5.9 
Total 
Responses 
13 20 1 34 100 
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Open-Response Fields Addressing Physical Barriers 
Twenty-nine respondents did not elaborate or provide further detail on the open-
response survey questions related to experiences with physical barriers to ocular 
pharmaceutical use.  Responses provided from five participants were brief and candid 
explanations of their physical barriers to ocular pharmaceutical adherence. One 
participant indicated the need for glasses in order to read the instructions. Another 
participant indicated he had only one arm and required a stint for their eye-lid. Two 
participants noted mechanical limitations of carpal tunnel and hand tremors. One 
participant indicated their Alzheimer’s disease as a mental limitation. For this research 
study each of the experiences provided on physical barriers to ocular pharmaceuticals 
were unique. These physical barrier experiences demonstrate a considerably wide range 
of what patients consider a physical barrier or limitation to ocular instillation. 
Open-Response Question Addressing Environmental Barriers 
Twenty-eight respondents did not elaborate or provide further detail on the open-
response survey questions related to experiences with environmental barriers to ocular 
pharmaceutical use.  Two participants indicated that location does impact their ability to 
use ocular pharmaceuticals, but did not elaborate further. Two participants described their 
experiences with environmental barriers. One participant described better accuracy 
instilling eye drops in darkness rather than in the light. The second participant who 
provided an experience described an important reminder technique based on the time of 
day for which they administer the ocular pharmaceutical. That technique, is to keep the 
ocular pharmaceuticals in a convenient and easy to remember location. 
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Summary 
Quantitative and qualitative data analysis demonstrated trends regarding elderly 
patient adherence to ocular pharmaceuticals and the impact of educational and physical 
barriers, supported the purpose of this research study. The findings identified that there 
were elderly patients who believed they were adhering to their ocular therapy. A majority 
of the participants in this research see a health care professional regularly to receive 
instructions on how to instill ocular pharmaceuticals. This research uncovered that most 
elderly patients using ocular pharmaceuticals indicated agreement that there are benefits 
to addressing areas of educational and physical barriers to ocular pharmaceutical 
adherence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 62 
 
 
Chapter V: Summary, Discussion, and Recommendations 
Introduction 
The purpose of this study was to assess and evaluate elderly patients’ attitudes 
and behaviors regarding educational and physical barriers and their impact on adherence 
to ocular pharmaceutical therapy. This research study strived to investigate how these 
two types of barriers contributed to low adherence rates for elderly patients undergoing 
ocular pharmaceutical therapy. The following research questions were examined in this 
research study: 
1. For elderly patients, how can the educational barrier of a lack of understanding of 
how to properly instill ocular pharmaceuticals be addressed and mitigated?  
2.  For elderly patients, how can physical barriers be addressed to improve the 
ability to properly self-administer eye drops as prescribed?  
Summary 
This research study included thirty-four respondents who were ages 65 years or 
older, currently undergoing ocular therapy, and being treated with a specific ocular 
pharmaceuticals- eye drops. The timeframe in which this study was conducted was 
during the fall 2014 through the spring 2015 semesters. Respondents by gender were 
38.2% (n= 13) male, 58.8% (n=20) were female, and 2.9% (n=1) who did not indicate a 
gender. The mean age of the eligible respondents was 87.65 years of age and range of 
ages of the respondents was 65 years to 99 years. Data were collected for this research 
study using a survey instrument. A printed version was distributed in-person at the Edina 
Senior Center and the Burnsville Center and an online version distributed by Zoomerang 
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™ survey tool. The survey questions were designed and tested in a pilot study to gather 
data about elderly patient’s attitudes, behaviors, and experiences regarding educational 
and physical barriers and their impact upon ocular pharmaceutical adherence. 
Discussion 
The population size of eligible respondents for this research study was reasonable 
provided the noted limitations. An assumption made by this researcher was that a higher 
percentage of ocular pharmaceutical users would be among the elderly population. Of the 
135 respondents who met the age inclusion criteria (of 65 years of age and older) only 61 
noted they were treating an eye condition, and of those 61 only 34 used ocular 
pharmaceuticals as part of their treatment of an eye condition or eye conditions. 
Therefore the sample population of respondents who are actually treating and ocular 
condition with eye drops was 27.2%.  
A survey question asked participants to indicate the number of eye drops lost and 
did not make it into the eye(s) per dose when used in ocular treatment. Forty-seven and 
one-tenth percent (n = 16) of respondents reported no drops were lost and 47.1% (n = 16) 
reported 1 to 2 drops were lost, and just 2.9 % (n = 1) reported loosing more than 5 drops. 
However, several studies reviewed that recorded greater loss than that reported by 
patients. Hennessy, Katz, Covert, Protzko, and Robin (2010) observed glaucoma patients 
instilling their ocular pharmaceuticals and found only 71% percent of subjects were able 
to get a single drop onto the eye following instructions. This indicates that self-reporting 
of loss by a patient may be less than the amount lost in practice. 
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Educational barriers 
The responses collected from respondents treating an ocular condition with ocular 
pharmaceuticals indicated strong agreement that reducing educational barriers was 
beneficial. Participants described their desire to address educational barriers with eye care 
providers and with ocular pharmaceutical products. One respondent stated literacy 
concerns and the use of illustrations as helpful. In regards to the statement, “The use of 
pictures to illustrate would improve your understanding of the eye drop instructions.” 
29.4% (n = 10) of study participants reported strongly agree and 17.6% (n = 6) reported 
somewhat agree suggesting that pictographic instructions would improve understating of 
instillation.  
Findings from this study about the educational experiences of the respondents 
exposed a desire for elderly patient education for first time ocular pharmaceutical users 
and increasing time with providers for education on instillation. Shea (2006, p.7) also 
promoted this suggestion for increased health education, as “during the medication 
education phase of the appointment can significantly improve adherence.” This study 
supports the desire for increased health education opportunities for ocular 
pharmaceuticals to improve elderly patient adherence to this class of medications. 
Physical barriers 
The responses collected from respondents treating an ocular condition with ocular 
pharmaceuticals expressed a strong agreement with improving upon physical barriers as a 
beneficial idea. There was strong support for larger font provisions, 58.8% (n = 20) 
reported strongly agree and 29.4% (n = 10) reported somewhat agree with the survey 
question statement, “Instructions in larger font would improve your ability to see and 
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read the instructions clearly.” Reducing this burdening factor has the potential to impact 
medication adherence. Shrank, Avorn, Rolon, and Shekelle, (2007) support label 
formatting such as the use of larger fonts, lists, headers, and white space, using simple 
language and logical organization to improve readability and comprehension. Findings 
from this study also demonstrate the research study participants’ interest in addressing 
physical barriers to instillation with dispenser aides. Specifically, 20.6% (n = 7) 
participants reported strongly agree and 29.4% (n = 10) reported somewhat agree with 
the statement, “An eye drop dispenser tool would improve your ability to properly use 
your eye drops.” The desire to improve instillation shows that elderly patients undergoing 
ocular pharmaceutical therapy are responsive to using an ocular pharmaceutical 
dispensing tool. This level of agreement by the research study population would suggest 
the need to research further and present this as a quality of healthcare need to eye care 
providers, other healthcare professionals dispensing ocular pharmaceuticals, and the 
manufacturing producers of ocular pharmaceuticals.   
This study also found through participant experiences that a variety of physical 
conditions that are not directly related to ocular conditions were self-reported as physical 
barriers. Respondents in this research study experienced hand tremors, Alzheimer’s 
disease, and carpal tunnel as physical barriers. One respondent indicated he is one-handed 
and required the use of a stump to hold eyelid. Each of these experiences indicates that 
ocular therapy is a unique treatment and providers and patients should work together to 
support successful treatments that overcome physical barriers. From the experiences 
evaluated in this study, adjustments could range from needing glasses to read instructions 
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to the use of a dispenser aid or stump. However, treatment options should be discussed 
and evaluated to suit the needs of each patients agreed upon ocular therapy plan. 
Limitation and Delimitations 
A limiting factor to in-person data collection was the timeframe. The Edina 
Senior Center and the Burnsville Senior Center are open primarily during daytime hours. 
During in-person table events collecting survey responses during social hour activities 
was more successful than planned structured activities at both senior centers. Table 
events during the social activities resulted in a higher volume of participants willing to 
participate in the research study. Those arriving at the senior center for an activity were 
able to leisurely talk to the researcher about the study and take the survey. During 
structured activity times, visitors of the senior centers did not want to stop at the table and 
declined interested in talking to the researcher. Online survey collection had a notably 
higher volume of respondents. Several factors may have contributed to the success of this 
survey collections method such as, elderly users of computers and Internet may be more 
technologically savvy than their peers. Additionally, the online survey participants had 
the liberty of taking the survey when there was a convenient time during the two-week 
timeframe in which the survey link was active.  
Another limiting factor was the sample population size of eligible participants. 
Establishing a partnership with an eye care clinic may result in a higher concentration of 
persons who are treated with ocular pharmaceuticals. Another way to recruit more 
eligible participants is to expand the inclusion criteria to include responses of non-ocular 
pharmaceutical users who are treating an eye condition to gather an alternative 
perspective on instillation. Increasing both the time available for data collection and the 
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eligible number of participants would provide more viable data to investigate ocular 
pharmaceutical adherence and the impact of educational and physical barriers. 
Recommendations for Health Education Profession 
Findings from this study provided data regarding attitudes, behaviors, and 
experience about elderly patient adherence to ocular pharmaceuticals and the impact of 
educational and physical barriers. These findings suggest there is a gap in the health 
education profession of the need for health educators and professionals to provide 
educational opportunities to elderly ocular therapy patients. Findings of this study 
demonstrate elderly participants sampled 38.2% (n = 13) reported strongly agreeing with 
the statement, “Having your health care professional demonstrate how to properly use 
your eye drops would improve your ability to use eye drops on your own.” In order to 
increase the knowledge base of elderly patients, it is essential to integrate this information 
into the patient education conversations at ocular therapy appointments. 
Revisiting the Health Belief Model used to support this study, this model will 
continue to aid health educators in identifying the perceived barriers to ocular 
pharmaceutical adherence and the equally important benefits of instilling ocular 
pharmaceuticals appropriately. As a supportive model, the Health Belief Model has 
proven suitable in this study and applied to developing data collection methods and 
strategies to improve ocular pharmaceutical education conversations between elderly 
patients and providers. 
Recommendations for Future Research 
Results of this research study indicate a need to gather data from a broader sample 
of elderly patients using ocular pharmaceuticals. This would enrich the knowledge base 
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available on educational and environmental barriers to ocular pharmaceutical adherence 
and increase the validity of findings from the attitudes, behaviors, and experiences.  
A recommendation this study makes is to increase the amount of detailed 
experiences elderly patients will share regarding their attitudes and behavior towards 
educational and physical barriers to using ocular pharmaceuticals. This could be an 
adjustment to data collection instruments. Re-formatting and repurposing of the open 
response questions in the form of a focus group or conducting interviews may elicit more 
detailed and descriptive responses in order to achieve the objective of gaining more 
knowledge than what is available. Using additional health education research techniques 
to investigate further would allow for deeper insight into educational and physical 
barriers to ocular pharmaceutical adherence. 
Additionally, the need to investigate possible interventions is evident from this 
study of elderly patient adherence to ocular pharmaceuticals and the impact of 
educational and physical barriers. Expanding on each of the targeted survey questions to 
gain more detail regarding the educational and physical barriers. Follow up needs 
assessments built from the questions focused on educational barriers could assess the 
impact of interventions focusing on video and illustrative instructions on elderly patient 
ocular pharmaceutical adherence. Follow up needs assessments built from the questions 
focused on physical barriers could assess the impact of interventions focusing on larger 
font formatting or the use of dispenser aides on elderly patient ocular pharmaceutical 
adherence. 
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15 NA NA NA NA Assist in 
squeezing the 
bottles or 
positioning 
the drop 
NA NA Brand name 
tools: 
Opticare, 
Autosqueeze
, Autodrop 
(images on 
p. 928) 
16 NA NA NA Elderly 
patients' 
noncompli
ance with 
A descriptive 
analysis of the 
literature 
A 
MEDLINE
® search of 
the 
1962 
to 
1997 
Clear 
associations 
have been 
established 
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medicatio
n 
regimens 
literature between 
elderly 
patients' 
medication 
adherence 
and race, 
drug and 
dosage form, 
number of 
medications, 
cost of 
medications, 
insurance 
coverage, 
and 
physician-
patient 
communicati
on.  
17 Brief 
Medicat
ion 
Questio
nnaire 
(BMQ) 
results 
The patients 20 patients Patients 
who need 
assistance 
with their 
medicatio
ns 
A five-item 
Regimen 
Screen that 
asks patients 
how they took 
each 
medication in 
the past week, 
a 2-item 
Belief Screen 
that asks 
about drug 
effects and 
bothersome 
features, and a 
2-item Recall 
Screen about 
potential 
difficulties 
remembering.  
Questionna
ire 
1998 Self-report 
tools for 
monitoring 
adherence 
can be useful 
in 
identifying 
patients who 
need 
assistance 
with their 
medications, 
assessing 
patient 
concerns, 
and 
evaluating 
new 
programs.  
18 Patient 
adheren
ce rates. 
Patients 
were divided 
by necessity 
and by 
concern. 
324 
Patients. 
Four 
chronic 
illness 
groups 
(asthma, 
renal, 
cardiac, 
and 
oncology)
. 
Patients 
ranked beliefs 
by topic area. 
Study used 
questionnaires 
to collect 
responses. 
Cross-
sectional 
study. 
1998 Considerable 
variation in 
reported 
adherence 
and beliefs 
about 
medicines 
within and 
between 
illness 
groups. 
19 NA NA NA NA NA NA NA   
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20 Educati
on 
progra
m 
effectiv
eness 
Patients' 
glaucoma 
knowledge, 
understandin
g of 
compliance 
and health 
motivation 
100 
persons 
Diagnosis 
of primary 
open 
angle 
glaucoma 
Questionnaire Questionna
ire 
1998 The 
interactive 
program and 
the didactic 
presentation 
were 
statistically 
the same 
21 NA NA NA NA NA Medication 
adherence 
scale. 
NA For provider 
use. 
22 Individ
ualize 
interven
tions 
for 
promoti
ng 
medicat
ion 
taking. 
Organization 
of the MAM 
may 
facilitate 
health care 
providers' 
abilities to 
improve 
medication 
adherence. 
NA Not 
specified 
The three core 
concepts 
identified in 
the model are: 
(a) Purposeful 
Action, (b) 
Patterned 
Behavior, and 
(c) Feedback.  
NA NA The MAM 
was 
structured 
with the idea 
that two 
types of 
nonadherenc
e contribute 
to 
inconsistent 
medication 
taking, the 
intentional 
decision to 
miss 
medications, 
and the 
unintentional 
interruptions 
that cause 
medications 
not to be 
taken. The 
three core 
concepts 
identified in 
the model 
are: (a) 
Purposeful 
Action, (b) 
Patterned 
Behavior, 
and (c) 
Feedback.  
23 Subject 
respons
es 
Situational 
obstacles 
71 patients Diagnosis 
of 
glaucoma 
Structured 
interviews 
recorded on 
audiotapes 
Hierarchica
l cluster 
analysis 
from 
interviews 
2000-
2002 
Taxonomy 
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24 NA NA NA Minority 
groups 
whose 
first 
language 
is not the 
language 
of the 
healthcare 
system. 
Barriers to the 
access of 
medication 
information 
by ethnic 
minorities 
include 
second 
language 
issues and 
cultural 
differences 
due to 
different 
health beliefs, 
together with 
the low socio‐
economic 
status often 
seen among 
ethnic 
minorities.  
Searched 
electronic 
databases 
and printed 
scientific 
journals 
focusing on 
(ethnic) 
minorities, 
health 
and/or 
(intercultur
al) 
communica
tion. Also a 
discussion 
group for 
references. 
Not 
speci
fied 
Only a few 
articles on 
intercultural 
communicati
on on 
medication 
or pharmacy 
information 
and one 
article on the 
improvement 
of 
intercultural 
communicati
on in the 
pharmacy. 
Barriers to 
the access of 
medication 
information 
by ethnic 
minorities 
include 
second 
language 
issues and 
cultural 
differences 
due to 
different 
health 
beliefs, 
together with 
the low 
socio‐
economic 
status often 
seen among 
ethnic 
minorities. 
25 Cost 
related 
drug 
adheren
ce. 
Insurance 
coverage. 
19581 
Medicare 
members. 
Participan
ts age 
sixty-five 
and older 
who were 
enrolled 
in 
Medicare 
in 2000. 
Four-fifths of 
the interviews 
were 
conducted by 
telephone. 
The rest in 
person. 
(2000) of 
the Health 
and 
Retirement 
Study 
(HRS), an 
ongoing 
longitudina
l survey of 
community
-dwelling 
older 
Americans. 
2000 This poor 
adherence 
tended to be 
more 
common 
among 
beneficiaries 
with no or 
partial 
medication 
coverage and 
was 
associated 
with poorer 
health and 
higher rates 
of 
hospitalizati
on.  
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26 Medicat
ion 
adheren
ce rates. 
Behavioral, 
educational, 
and 
combined 
interventions
. 
10 subjects 
per 
interventio
n group 
were 
included. 
61 articles 
were 
evaluated. 
Homogen
ous cohort 
patients 
Randomized 
controlled 
trials were 
studied. 
A literature 
search was 
performed 
with 
MEDLINE
, 
Internation
al 
Pharmaceut
ical 
Abstracts, 
PsychLIT, 
ERIC, and 
EMBASE.  
1966 
to 
Dece
mber 
2000. 
No single 
strategy 
appeared to 
be best. 
27 NA NA NA NA NA NA NA Five 
dimensions 
developed 
by the 
WHO. Cited 
by several 
studies. 
28 Subject 
respons
es. 
Information 
concerning 
dosing of 
their 
medicines. 
500 
patients 
and 
prescribers. 
Glaucoma 
therapy. 
Interviews by 
telephone 
Interview. 2000-
2003 
  
29 NA NA 134 articles 
included. 
NA Abstracts of 
identified 
articles were 
assessed by at 
least two 
reviewers and 
the full 
articles were 
assessed by 
one reviewer 
and checked 
by at least one 
other 
reviewer. 
Data on the 
design, 
analysis and 
relevant 
findings were 
extracted. 
Six 
electronic 
databases 
were 
searched 
using the 
following 
categories 
of search 
terms: 
health care 
professiona
ls, 
patients/co
nsumers, 
medicine-
taking/pres
cribing and 
communica
tion.  
Studi
es 
publi
shed 
betw
een 
1991 
and 
2000 
were 
inclu
ded 
  
30 NA NA NA NA Review 
design and 
physical 
characteristics 
of dropper tip 
and bottle, 
physico-
chemical 
properties of 
the solution, 
and the 
manner the 
patient 
dispenses 
drops 
NA NA In this 
review, the 
technical, 
pharmaceuti
cal, and 
therapeutic 
aspects of 
eye drop 
formation 
and delivery 
are 
presented.  
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31 NA NA 86 Studies. Self-
report 
versus 
non self-
report 
studies. 
A literature 
search was 
conducted to 
identify 
published 
reports in 
which self-
report and 
non-self-
report 
measures of 
adherence 
were used 
within the 
same study. 
The 
concordanc
e of 
measures 
within each 
study was 
categorized 
as high, 
moderate, 
or low. 
2004   
32 NA NA NA NA Review of 
interventions 
designed to 
address non-
adherence to 
therapeutic 
regimens. 
Literature 
review. 
Various 
sources. 
Queen's 
University 
in Belfast, 
Northern 
Ireland. 
NA No 
consensus in 
the literature 
that age is a 
predictor of 
poor 
adherence. 
33 NA NA NA NA NA National 
initiative 
by the Case 
Manageme
nt Society 
of America 
to train 
case 
managers 
in 
psychosoci
al 
behavioral 
change and 
apply 
adherence 
interventio
ns through 
a set of 
evidence-
based 
guidelines 
NA Adherence, 
formerly 
referred to as 
compliance, 
is a patient-
centered 
term. It 
suggests that 
patients 
carry out and 
maintain 
certain 
behaviors, 
such as 
taking 
medications, 
after making 
an informed 
choice in a 
supportive 
environment. 
34 NA NA NA NA NA Review of 
conducted 
studies. 
NA Good review 
of tools 
available. 
35 NA NA NA NA NA NA NA Website 
designed to 
help elderly 
outpatients. 
36 NA NA NA NA NA NA NA Editorial 
article. 
Recommend
ations to 
enhance 
adherence to 
medications. 
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37 Older 
adults' 
medicat
ion 
adheren
ce. 
Personal and 
cultural 
beliefs. 
14 studies. Adults 
who are 
often 
prescribed 
medicatio
ns for age-
related 
chronic 
disorders.  
The majority 
of the studies 
in the review 
evaluated 
older adults' 
medication 
adherence by 
self-report and 
used cross-
sectional 
designs and 
convenience 
samples.  
Systematic 
literatures 
searches 
using ten 
databases. 
A review 
of research 
studies 
published 
in journals 
across 
different 
disciplines. 
NA   
38 NA NA NA NA NA NA NA   
39 NA NA NA NA NA NA NA   
40 Subject 
respons
es. 
Medication 
adherence 
questions. 
NA National 
stratified 
random 
sample of 
communit
y-
dwelling 
Medicare 
members 
65 years 
and older. 
Nationwide 
cross-
sectional 
survey. 
Factor 
analysis of 
survey 
responses. 
2005-
2006 
  
41 Effect 
size of 
interven
tions 
and 
clinical 
adheren
ce. 
Informationa
l, behavioral, 
and/or 
social, or 
combined 
interventions
. 
37 eligible 
trials. 
Patients 
with 
chronic 
medical 
conditions
. 
Study 
characteristics 
and results for 
adherence and 
clinical 
outcomes 
were 
extracted. 
Published 
Randomize
d 
controlled 
trials 
Janua
ry 
1967 
to 
Septe
mber 
2004 
  
42 NA NA NA Generaliz
ed eye 
drop use 
NA National 
Institute of 
Health 
NA Illustrative 
instructions 
43 NA NA Not 
specified. 
Participan
ts had 
moderate/
severe 
glaucoma 
diagnosed 
for >1 
year and 
prescribed 
2 or more 
medicatio
ns. 
Qualitative 
methodology 
investigated 
aspects of 
adherence. 
Recruited 
patients 
attended 
focus 
groups or 
had a 
home-
based 
semi-
structured 
interview. 
2006   
44 NA NA NA NA NA NA NA Theoretical 
support and 
definitions 
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45 Patient 
success 
rate of 
ability 
to 
instill 
eye 
drop as 
instruct
ed. 
Eye drop 
container 
type. Control 
group: 
applied 
drops from 
single-use 
eye drop 
containers. 
Group B: 
traditional 
eye drop 
bottle. 
44 patients.  Patients 
aged ≥80 
years who 
had no 
physical 
or mental 
conditions 
hindering 
self-
applicatio
n of eye 
drops 
Two 
investigators, 
who 
documented 
practical 
problems 
during the 
procedure in a 
checklist, 
observed 
patients. 
Randomize
d 
controlled 
study 
Not 
speci
fied. 
Frequency of 
problems 
during 
opening and 
self-
application 
of single-use 
eye drop 
containers in 
the study 
group 
showed an 
inverse 
correlation 
to visual 
acuity in the 
better eye 
and previous 
experience 
with this 
kind of eye 
drop 
container. 
46 NA NA NA Measuring 
adherence 
in each 
study  
Articles were 
selected if 
they reported 
an 
uncompounde
d RCT of an 
intervention to 
improve 
adherence 
with 
prescribed 
medications, 
measuring 
both 
medication 
adherence and 
treatment 
outcome, with 
at least 80% 
follow-up of 
each group 
studied and, 
for long-term 
treatments, at 
least six 
months 
follow-up for 
studies with 
positive initial 
findings.  
Searches of 
The 
Cochrane 
Library, 
MEDLINE
, CINAHL, 
EMBASE, 
Internation
al 
Pharmaceut
ical 
Abstracts 
(IPA), 
PsycINFO 
(all via 
OVID) and 
Sociologica
l Abstracts 
(via CSA) i 
with no 
language 
restriction.  
Jan-
07 
  
47 NA NA 63 studies. Older 
adults > 
60 years 
of age 
who are 
self-
medicatin
g. 
Literature 
review. 
Computeriz
ed database 
searches, 
journal 
hand 
searches, 
and 
ancestry 
searches. 
1977-
2005 
Low 
medication 
adherence 
rates among 
some elderly 
contributes 
to 
inadequate 
pharmacolog
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ical 
management 
of illnesses 
48 NA NA NA NA Review of 
evidence 
based 
interventions. 
Review of 
conducted 
studies. 
2005 This is a 
handbook. 
49 Patient 
adheren
ce 
medicat
ion 
rates. 
Watched an 
educational 
video, 
reviewed 
current 
barriers to 
drop-taking 
and possible 
solutions 
with a study 
coordinator, 
received 
regular 
phone call 
reminders, 
and had 
audible and 
visible 
reminders. 
66 patients. Patients 
with 
glaucoma 
being 
treated 
with a 
prostaglan
din analog 
in one or 
both eyes. 
Randomized 
controlled 
study. 
Interventio
n. 
Nove
mber 
2006 
and 
June 
2007 
  
50 NA NA NA American 
adults. 
Articles were 
grouped and 
summarized 
into three 
broad 
categories 
(nonadherenc
e, health 
literacy, and 
communicatin
g health 
information to 
patients), with 
an emphasis 
on the use of 
written patient 
information in 
health care 
and pharmacy 
practice in 
particular. 
Searches of 
Medline, 
PubMed, 
and 
Internation
al 
Pharmaceut
ical 
Abstracts 
databases 
were 
conducted 
using one 
or more of 
the 
following 
terms 
adherence/
nonadheren
ce, 
compliance
/noncompli
ance, 
printed/writ
ten 
information
, literacy, 
patient 
education, 
communica
tion, and 
health 
literacy.  
2008   
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51 Patient 
adheren
ce rates. 
Participants 
were divided 
into a group 
with High 
Cognitive 
Function 
(HCF) or 
Low 
Cognitive 
Function 
(LCF) based 
on their 
scores on the 
ADAS-Cog. 
38 patients. Patients 
aged 65 
years and 
older. 
This was a 
cross-
sectional 
study of the 
ability of 
independently 
living healthy 
elders to 
follow a 
medication 
regimen.  
Adherence 
was 
measured 
using an 
electronic 
7-day 
pillbox. 
2009   
52 Outcom
e of 
confere
nces. 
Educational 
meetings 
alone or 
combined 
with other 
interventions
. 
81 trials 
involving 
more than 
11,000 
health 
professiona
ls. 
Profession
als’ 
conferenc
e. 
Randomized 
controlled 
trials of 
educational 
meetings that 
reported an 
objective 
measure of 
professional 
practice or 
healthcare 
outcomes. 
Searching 
the 
Cochrane 
Effective 
Practice 
and 
Organizatio
n of Care 
Group 
Trials 
Register 
and 
pending 
file. 
1999-
2006 
Educational 
meetings 
alone or 
combined 
with other 
interventions 
can improve 
professional 
practice and 
healthcare 
outcomes for 
the patients.  
53 Effectiv
eness of 
interven
tions. 
Tailored 
interventions
. 
26 studies. Randomiz
ed 
controlled 
trials 
(RCTs) of 
interventi
ons. 
Meta-
regression to 
compare 
interventions 
tailored to 
address 
identified 
barriers to 
change with 
either no 
interventions 
or an 
intervention(s
) not tailored 
to the barriers. 
Database 
searches 
without 
language 
restrictions, 
from 
inception 
until 
August 
2007: 
MEDLINE
, 
EMBASE, 
CINAHL, 
BNI and 
HMIC.  
2007-
2009 
Interventions 
tailored to 
prospectivel
y identified 
barriers are 
more likely 
to improve 
professional 
practice than 
no 
intervention 
or 
disseminatio
n of 
guidelines. 
54 NA NA NA NA NA Various 
references 
NA Good 
definitions 
and tools for 
educators 
55 NA NA NA NA NA NA NA Recommend
ation to 
share 
medication 
management 
responsibiliti
es following 
the patient-
centered 
medical 
home model 
of care  
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56 Eye 
drop 
adminis
tration. 
Subjects 
with 
glaucoma or 
retinal 
diseases. 
409 
subjects 
(205 
glaucoma, 
204 retina). 
Glaucoma 
or retinal 
diseases 
with 
visual 
acuity of 
20/60 or 
worse in 1 
eye, 
significant 
field loss, 
or both. 
Study was 
divided by 
diagnosis. 
Recorded 
clinical 
examinatio
n. 
2010-
2011 
Both groups 
wasted 
drops, 
contaminate
d bottles, 
and had 
inaccurate 
perception of 
their 
abilities.  
57 NA NA NA Elderly 
patients 
(i.e., ≥65 
years of 
age) in the 
United 
States. 
Nonsystemati
c reviews 
were 
excluded, as 
were studies 
that focused 
specifically on 
people who 
were 
homeless or 
substance 
abusers, or 
patients with 
psychotic 
disorders, 
tuberculosis, 
or HIV 
infection, 
because of the 
unique 
circumstances 
that surround 
medication 
adherence for 
each of these 
populations. 
The 
PubMed 
and 
PsychINFO 
databases 
were 
searched 
for articles 
published 
in English 
between 
January 
1998 and 
January 
2010 
1998-
2010 
Described 
“predictors,” 
“facilitators,
” or 
“determinant
s” of 
medication 
adherence. 
58 NA NA NA NA NA NA NA   
59 NA NA NA NA NA Review of 
other 
studies. 
NA Tips for the 
pharmacist 
include 
demonstratin
g proper 
instillation 
technique 
each time a 
patient 
presents a 
new 
prescription, 
and observe 
the patient 
applying 
drops. 
Pharmacists 
should also 
remind 
patients to 
include eye 
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drops on 
their 
medication 
lists, and 
insist that 
they need 
them if they 
are 
hospitalized  
60 Safe 
medicat
ion use. 
Illumination, 
interruptions 
and 
distractions, 
sound and 
noise, 
physical 
design and 
organization, 
and 
medication 
safety zones. 
NA NA The reports 
described in 
this column 
were received 
through the 
ISMP 
Medication 
Errors 
Reporting 
Program 
(MERP). 
Errors, close 
calls, or 
hazardous 
conditions 
may be 
reported on 
the ISMP 
Web site 
(www.ismp.or
g) or 
communicate
d directly to 
ISMP by 
calling 1-800-
FAIL-SAFE 
or via e-mail 
at 
ismpinfo@is
mp.org.  
The reports 
described 
in this 
column 
were 
received 
through the 
ISMP 
Medication 
Errors 
Reporting 
Program 
(MERP). 
Errors, 
close calls, 
or 
hazardous 
conditions 
may be 
reported on 
the ISMP 
Web site 
(www.ismp
.org) or 
communica
ted directly 
to ISMP by 
calling 1-
800-FAIL-
SAFE or 
via e-mail 
at 
ismpinfo@
ismp.org.  
Not 
speci
fied 
Standards 
are provided 
in five key 
areas—
illumination, 
interruptions 
and 
distractions, 
sound and 
noise, 
physical 
design and 
organization, 
and 
medication 
safety zones.  
61 The 
ability 
to 
assess 
concord
ance. 
Patients who 
were 
administered 
the 
MedAdhIR-
ST questions 
and those 
given the 
MAQ 
questions. 
Not 
specified. 
Communit
y-
dwelling 
elderly 
population
. 
A prospective, 
observational 
pilot study 
comparing the 
reliability and 
validity of the 
MedAdhIR-
ST compared 
against the 
Medication 
Adherence 
Questionnaire 
(MAQ). 
Questionna
ire. 
Explorator
y factor 
analysis. 
2012 Accepted in 
2014.  
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62 Patient 
adheren
ce to 
medicat
ion. 
Living with 
drugs, taking 
medication, 
belief about 
drugs and 
relationship 
with health 
professionals
. 
NA People 
aged 65 or 
more and 
with 
chronic 
illness. 
Data was 
collected by 
two focus 
groups. The 
content of 
discussion 
was analyzed 
from verbatim 
transcript and 
identifying 
categories and 
sub-categories 
emerged, 
leading to the 
construction 
of a diagram 
analysis. 
Focus 
groups. 
2011-
2012 
The elderly 
suggest that 
the 
relationship 
with health 
professionals 
is essential 
in 
medication 
management 
and they 
reported that 
the 
information 
given by the 
nurse during 
consultation 
is very 
important. 
63 NA NA NA NA NA NA NA   
64 NA NA NA NA NA Various 
references. 
NA CDC calls 
out 
educational 
pointers. 
65 NA NA NA NA Annual report Various 
references 
NA Prepared by 
the national 
community 
of 
pharmacists 
association. 
Americans 
had an 
overall 
compliance 
score of a 
C+. 
66 Patient 
adheren
ce 
medicat
ion 
rates. 
Patients 
receiving 
patient 
centered 
health 
promotion 
approach. 
NA 27 new 
and 
establishe
d patients 
receiving 
glaucoma 
treatment.  
Interviews. The 
interviews 
were 
transcribed 
and then 
analyzed 
thematicall
y. 
2012 Nine 
categories of 
health 
education 
needs were 
identified. 
67 NA NA NA General 
population
s of eye 
drop users 
and eye 
care 
providers. 
Discussion 
and 
contribution 
by health 
professionals 
working in 
optometry, 
ophthalmolog
y, medicine, 
pharmacy, 
and 
development 
Various 
references. 
Global 
health 
conference. 
NA Good topic 
discussion 
forum. 
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68 Particip
ant 
respons
e. 
Movement 
from 
periodic to 
continuous 
operation. 
Unknown- 
some 
cultures 
provided 
group 
responses. 
 Māori, 
Pacific 
and Asian 
population
s residing 
in New 
Zealand. 
Disproportion
ate area 
sampling and 
a dual frame 
design. 
Use of core 
questions 
with 
rotating 
topic 
modules to 
improve 
flexibility 
in survey 
content; 
and 
opportuniti
es for 
ongoing 
improveme
nts and 
efficiencies
, including 
linkage to 
administrat
ive 
datasets. 
  Applicable 
for survey 
design. Not 
specific to 
any health 
condition. 
69 NA NA NA NA NA NA NA   
70 NA NA NA NA NA Various 
references 
NA Good for 
definitions 
and 
utilization 
rates. 
71 NA NA NA NA NA Various 
references 
NA   
72 NA NA NA NA NA NA NA University of 
Arkansas 
Medical 
Sciences 
 
 104 
 
 
Appendix B: Approval Institutional Review Board 
 
 
- 1 - Generated on IRBNet
 

	


		
 !
"#"$%&&&'("" 
#
#))	"
 
*
)	)
"!+* 
),
	)
#
"
# !)
"
!+$
-.-"-"
/	 !
"
!#
  -
!,	
+0#
",,1##!
2

3#-!1
#
..!	!	))!!.	!	+**
	*	!!
  -
"
,
#)
#4!#	!	!!4#,	##4!	))#!# )!!
# 
,!	

*

,,) 
) 
#!#!	+2	"
#, 
) 
#!#	!	!	,,
!
)
"
#5	
*,	"	)*	
6	 *7!!)
8)!#,
!
)
#
#,9
	
2	!**
"+
:
  -
",	!	!,#)
"#

"!!

,*
  -
"
+;#	
)* "	

)"")#!	"	!)##		!		*	!!	*
<"!	6	!
=! >>4
+*#!	+	>>)##	
#+*"?+"
!#)"		@#	*.
#
)! ##).+
:#) 
"#-!4
=?!! #!",*
#
##4!4#)#!#,*!#
!)	")
#

123,A
!+,"
-!123,#,A
*"#>!!! #!"
,,"".#4$<#!#*1
##
#)$ )	! !#"#=! >>4
+*#!	+	>>
!#4)#!#,*!+ ,?+
2#)"


1
B
"++
<#



	"<
"!#(++
<<


 105 
 
 
Appendix C: In-Person Consent Form 
Privacy and consent 
• Purpose: The purpose of this study is to learn how patients who are using 
eye drops to treat eye conditions perceive the educational and physical 
barriers to effective use. You must currently be treated for an eye 
condition to take part in this study. 
• What we will ask: If you agree to be a participant in this study, we will 
gather your responses to the survey questions. The survey questions will 
take about 5 minutes to complete. The open response questions about 
treatment of your eye condition, the educational or instructional barriers, 
physical limitations, the environment, and how you feel this impacts your 
ability to use eye drops will take about an additional 5 minutes to 
complete.  
• Risks: There is the risk that you could find a few of the questions about 
your eye conditions to be sensitive. I do not anticipate any risks to you 
participating in this study other than risks experienced in daily life.  
• Benefits: There are no benefits to you.  
• Compensation: There is no compensation for your participation. 
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• Confidentiality: The responses from this study will remain confidential. 
Any publicly available report will omit any information that could make it 
possible for you to be identified. Responses will be stored in a password-
protected file accessible only by the researchers. 
• Voluntary Participation: Participation is this study is voluntary. Any 
questions that you do not want to answer may be skipped. You are free to 
leave the study at any time without prejudice. 
• Questions: This research project is being directed by Dr. Judith Luebke.  
You can contact Dr. Luebke at 507-389-5938 or judith.luebke@mnsu.edu 
about any concerns you have about this project.  You also may contact the 
Minnesota State University, Mankato Institutional Review Board 
Administrator, Dr. Barry Ries, at 389-1242 or barry.ries@mnsu.edu with 
any questions about research with human participants at Minnesota State 
University, Mankato. 
Statement of Consent: I have read the above information and have 
received answers to any questions I asked. I consent to take part in the study. 
Participants should initial each page. 
Initials:____ 
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Submitting the completed survey will indicate your informed consent to 
participate.  
Printed Name__________________  
Your Signature__________________     Date __________ 
The researchers will keep this consent form for a minimum of three years 
beyond the end of the study. You may request a copy of this form for your 
records. 
Thank you, for your response and participation. 
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Appendix D: Online Consent Form 
ONLINE/ANONYMOUS SURVEY CONSENT 
You are requested to participate in research supervised by Dr. Judith K. Luebke 
on elderly patient adherence to ocular pharmaceuticals and impact of educational and 
physical barriers. This survey should take about 10 minutes to complete. The goal of this 
survey is to understand how patients who are using eye drops to treat eye conditions 
perceive the educational and physical barriers to effective use, and you will be asked to 
answer questions about that topic. If you have any questions about the research, please 
contact Dr. Luebke at Judith.luebke@mnsu.edu.  
 
Participation is voluntary.  You have the option not to respond to any of the 
questions. You may stop taking the survey at any time by closing your web browser. 
Participation or nonparticipation will not impact your relationship with Minnesota State 
University, Mankato. If you have questions about the treatment of human participants and 
Minnesota State University, Mankato, contact the IRB Administrator, Dr. Barry Ries, at 
507-389-2321 or barry.ries@mnsu.edu.  
 
Responses will be anonymous. However, whenever one works with online 
technology there is always the risk of compromising privacy, confidentiality, and/or 
anonymity. If you would like more information about the specific privacy and anonymity 
risks posed by online surveys, please contact the Minnesota State University, Mankato 
Information and Technology Services Help Desk (507-389-6654) and ask to speak to the 
Information Security Manager.  
 
There is the risk that you could find a few of the questions about your eye 
conditions to be sensitive. The risks of participating are no more than are experienced in 
daily life.  
 
There are no direct benefits for participating. Future studies on ocular 
pharmaceutical could make use of this research. 
 
Submitting the completed survey will indicate your informed consent to 
participate and indicate your assurance that you are at least 18 years of age.  
 
Please print a copy of this page for your future reference.  
 
MSU IRBNet ID# 720717      
Date of MSU IRB approval: February 24, 2015 
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Appendix E: Survey instrument 
Educational and Physical Barriers to Eye Drop Use 
This survey asks questions about perceptions of educational and physical 
barriers to learn about using eye drops to treat eye conditions effectively. 
 
General Questions 
1. What is your age in years? ____ 
2. What is your gender? M, F, Prefer not to answer 
3. What is your eye condition(s)? _____ 
If you are not treating an eye condition(s), please indicate ‘none’ and 
do not answer the following questions.  
4. Do you use eye drops to treat your eye condition? ______ 
If you are not using eye drops please indicate ‘no’ and do not answer 
the following questions.  
 
Treatment 
1. How frequently do you see your or eye care provider? 
 - Never     
          - 1time each year 
 - 2 times each year  
              - 3 times each year  
          - 4 times or more each year 
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2. Who provides you with instructions on how to use your eye drops?  
 - Optometrist or Ophthalmologist 
 - General or Primary Physician 
 - Physicians’ assistant 
 - Nurse 
 - Pharmacist 
 - Other: Please, describe _______________ 
 - No one 
 
3. How many eye drop medications do you use to treat you eye condition? 
 - One 
 - Two 
 - Three or more 
 
4. How long have you been using eye drops to treat your eye condition? 
 - Less than 1 week 
 - 1 to 2 weeks 
 - 3 or more weeks 
 
5. How many eye drops do not make it into your eye(s) per dose? 
 - No drops per dose 
 - 1 to 2 drops per dose 
 - 3 to 4 drops per dose 
 - More than 5 drops per dose 
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Education/Instructions 
Survey Instructions: Please indicate your level of agreement with the 
following statements. 
1. Instructions on the eye drop box are clear and easy to understand 
Strongly  Somewhat    Indifferent      Somewhat        Strongly 
Agree  Agree           Disagree         Disagree 
1  2     3      4          5 
2. Words used to explain instructions for your eye drops are clear to 
understand  
Strongly  Somewhat    Indifferent      Somewhat        Strongly 
Agree  Agree           Disagree         Disagree 
1  2     3      4          5 
3. The use of pictures to illustrate would improve your understanding of the 
eye drop instructions. 
Strongly  Somewhat    Indifferent      Somewhat        Strongly 
Agree  Agree           Disagree         Disagree 
1  2     3      4          5 
4. The use of a video demonstration would improve your understanding of 
the eye drop instructions. 
Strongly  Somewhat    Indifferent      Somewhat        Strongly 
Agree  Agree           Disagree         Disagree 
1  2     3      4          5 
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Physical/Mechanics 
Survey Instructions: Please indicate your level of agreement with the 
following statements. 
 
1. Instructions in larger font would improve your ability to see and read the 
instructions clearly. 
Strongly  Somewhat    Indifferent      Somewhat        Strongly 
Agree  Agree           Disagree         Disagree 
1  2     3      4          5 
 
2. Having your health care professional demonstrate how to properly use 
your eye drops would improve your ability to use eye drops on your own. 
 Strongly  Somewhat    Indifferent      Somewhat        Strongly 
Agree  Agree           Disagree         Disagree 
1  2     3      4          5 
 
3. An eye drop dispenser tool would improve your ability to properly use 
your eye drops. 
Strongly  Somewhat    Indifferent      Somewhat        Strongly 
Agree  Agree           Disagree         Disagree 
1  2     3      4          5 
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Open Response Questions 
1. What do you believe are educational barriers to effective use (examples of 
educational barriers include, but are not limited to complex instructions or 
the use of confusing terminology)? In your opinion, how could the 
instructions for your eye drops be improved? 
 
 
 
2. Do you have any physical limitation that makes using eye drops difficult? 
Does this limitation require additional tools or devices to assist in using eye 
drops? 
 
 
 
3. Does the location of where you instill eye drops (your environment- an 
example is your bathroom at home) impact your ability to use them? 
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Appendix F: Edina Senior Center Permission 
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Appendix G: Burnsville Senior Center Permission 
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